National Health Act 1953 Determinations under sections 85, 85A and 88 (No. PB 20 of 2007) (Cth)

Case
No judgment structure available for this case.

COMMONWEALTH OF AUSTRALIA

National Health Act 1953

PHARMACEUTICAL BENEFITS

DETERMINATIONS UNDER SECTIONS 85, 85A AND 88

No. PB 20 of 2007

I, STEPHEN DELLAR, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, pursuant to sections 85, 85A and 88 of the National Health Act 1953, hereby make the following Determinations:

1.          These Determinations commence on 1 April 2007.

2.          The Determinations (No. PB 12 of 2007) under sections 85, 85A and 88 of the National Health Act 1953 made on 14 February 2007 with effect from 1 March 2007 are repealed.

3.          In these Determinations:

“Act” means the National Health Act 1953;

“base-priced drug” means —

(a)        in relation to ranitidine hydrochloride (tablet, effervescent, equivalent to 150 mg ranitidine or syrup equivalent to 150 mg ranitidine per 10 mL, 300 mL): cimetidine or famotidine or nizatidine or ranitidine hydrochloride (tablet equivalent to 150 mg ranitidine or tablet equivalent to 300 mg ranitidine); or

(b)        in relation to amlodipine besylate or lercanidipine hydrochloride or nifedipine (tablet 20 mg (controlled release)): felodipine or nifedipine (tablet 10 mg or tablet 20 mg or tablet 30 mg (controlled release) or tablet 60 mg (controlled release));

“CFC” means chlorofluorocarbon;

“CFU” means colony forming unit;

“electronic communication” has the meaning given by subsection 5(1) of the Electronic Transactions Act 1999;

“g” means gram;

“I.M.” means intramuscular;

“I.U.” means international unit;

“I.V.” means intravenous;

“kg” means kilogram;

“L” means litre;

“m” means metre;

“Medicare Australia CEO” means the Chief Executive Officer of Medicare Australia;

“mg” means milligram;

“mL” means millilitre;

“mm” means millimetre;

“mmol” means millimole;

“palliative care patient”, in relation to a purpose specified in Part 2 of the Second Schedule to these Determinations, means a patient with an active, progressive, far-advanced disease, and for whom the prognosis is limited and the focus of care is the quality of life;

“PBS” means Pharmaceutical Benefits Scheme;

“Regulations” means the National Health (Pharmaceutical Benefits) Regulations 1960 made under the Act.

4.          For the purposes of subsection 85(3) of the Act, where the strength, type of unit, size of unit or other particulars of form are specified in the column headed “Form” in the First or Second Schedule to these Determinations in relation to a drug or medicinal preparation referred to in subsection 85(2) of the Act the name of which is specified in that Schedule, those particulars refer to the form or forms of the drug or medicinal preparation that is or are allowable for the purposes of Part VII of the Act to the effect that the drug or medicinal preparation in that form or in each of those forms is a pharmaceutical benefit when prescribed by a medical practitioner.

4A.      For the purposes of subsection 85(3) of the Act, where a form is specified in the column headed “Form” in the Fourth Schedule to these Determinations, that particular refers to the form of a medicinal preparation, which is composed of one or more of the drugs or medicinal preparations specified in Schedule 4 to the Declaration under subsection 85(2) of the Act with or without the addition of one or more of the substances specified in Schedule 5 to that Declaration, that is allowable for the purposes of Part VII of the Act to the effect that the medicinal preparation in that form is a pharmaceutical benefit when prescribed by a medical practitioner.

5.          For the purposes of subsection 88(1A) of the Act, where the strength, type of unit, size of unit or other particulars of form are specified in the column headed “Form” in the Third Schedule to these Determinations in relation to a drug or medicinal preparation referred to in subsection 85(2) of the Act the name of which is specified in that Schedule, those particulars refer to the form or forms of the drug or medicinal preparation that is or are allowable for the purposes of Part VII of the Act to the effect that the drug or medicinal preparation in that form or in each of those forms is a pharmaceutical benefit referred to in subsection 88(1A) of the Act for the supply of which a participating dental practitioner is authorised to write a prescription.

6.          The purposes set out in the column headed “Purposes” in Part 2 of the First or Second Schedule to these Determinations are the only purposes for which a medical practitioner may prescribe the maximum quantities and numbers of repeats specified in that Part in relation to those pharmaceutical benefits specified in that same Part.

7.          The purposes set out in the column headed “Purposes” in Part 2 of the Third Schedule to these Determinations are the only purposes for which a participating dental practitioner may prescribe the maximum quantities specified in that Part in relation to those pharmaceutical benefits specified in that same Part.

8.          For the purposes of subsection 85A(2)(c) of the Act, the manner of administration, if any, set out in the column headed “Manner of administration” in relation to a pharmaceutical benefit, the name of which is specified in:                

(a)        the First or Second Schedule to these Determinations, is the only manner in which a medical practitioner may, in a prescription, direct the pharmaceutical benefit to be administered; or

(b)        the Third Schedule to these Determinations, is the only manner in which a participating dental practitioner may, in a prescription, direct the pharmaceutical benefit to be administered.

9.          For the purposes of subsection 85A(2)(a) of the Act, the maximum quantity or number of units of a pharmaceutical benefit that may, in one prescription, be directed to be supplied on any one occasion is:                

(a)        where the name of the pharmaceutical benefit is specified — 

(i)         in Part 1 of the First Schedule to these Determinations — the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum quantity” in relation to the pharmaceutical benefit; or

(ii)        in Part 2 of the First Schedule to these Determinations and the pharmaceutical benefit is prescribed in accordance with the provisions of the column headed “Purposes” — the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum quantity” in relation to the pharmaceutical benefit; or

(iii)       in Part 1 of the Second Schedule to these Determinations — the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum quantity” in relation to the pharmaceutical benefit; or

(iv)      in Part 2 of the Second Schedule to these Determinations and the pharmaceutical benefit is prescribed in accordance with the provisions of the column headed “Purposes” — the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum quantity” in relation to the pharmaceutical benefit; or

(v)       in Part 1 of the Third Schedule to these Determinations — the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum quantity” in relation to the pharmaceutical benefit; or

(vi)      in Part 2 of the Third Schedule to these Determinations and the pharmaceutical benefit is prescribed in accordance with the provisions of the column headed “Purposes” — the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum quantity” in relation to the pharmaceutical benefit; or

(b)        in any other case — the quantity or number, if any, specified in the column headed “Maximum quantity” in the Fourth Schedule to these Determinations in relation to the form of the pharmaceutical benefit.

10.        For the purposes of subsection 85A(2)(b) of the Act, the maximum number of occasions, if any, on which the supply of a pharmaceutical benefit may, in one prescription, be directed by a medical practitioner to be repeated is:                

(a)        where the name of the pharmaceutical benefit is specified — 

(i)         in Part 1 of the First Schedule to these Determinations — the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum number of repeats” in relation to the pharmaceutical benefit; or

(ii)        in Part 2 of the First Schedule to these Determinations and the pharmaceutical benefit is prescribed in accordance with the provisions of the column headed “Purposes” — the quantity or number, if any, in that Part of the Schedule in the column headed “Maximum number of repeats” in relation to the pharmaceutical benefit; or

(iii)       in Part 1 of the Second Schedule to these Determinations — the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum number of repeats” in relation to the pharmaceutical benefit; or

(iv)      in Part 2 of the Second Schedule to these Determinations and the pharmaceutical benefit is prescribed in accordance with the provisions of the column headed “Purposes” — the quantity or number, if any, in that Part of the Schedule in the column headed “Maximum number of repeats” in relation to the pharmaceutical benefit; or

(b)        in any other case — the number, if any, specified in the column headed “Maximum number of repeats” in the Fourth Schedule to these Determinations in relation to the form of the pharmaceutical benefit.

11.        The following purposes are specified in relation to each pharmaceutical benefit the name of which is specified in Part 2 of the First or Second Schedule to these Determinations:                

(a)        where a class of persons is specified in the column headed “Purposes” — that the pharmaceutical benefit is to be supplied for the treatment of a person included in that class of persons;

(b)        where a disease or condition is specified in the column headed “Purposes” — 

(i)         if subsubparagraph (ii) does not apply — that the pharmaceutical benefit is to be supplied for the treatment of that disease or condition in relation to any person; or

(ii)        if the disease or condition is specified in relation to a specified class of persons — that the pharmaceutical benefit is to be supplied for the treatment of that disease or condition in a person included in that class of persons;

(c)        where a purpose is specified in the column headed “Purposes” — that the pharmaceutical benefit is to be supplied for that purpose;

(d)        where it is specified in the column headed “Purposes” that compliance with authority procedures set out in subparagraph 11(d) is required — that a medical practitioner has submitted to the Medicare Australia CEO a prescription for the supply of the pharmaceutical benefit: 

(i)         by preparing and signing the prescription: 

(A)       in a form approved by the Secretary and completed by the medical practitioner in ink in his or her own handwriting; or

(B)       in a form, prepared by means of a computer, that is in accordance with the form approved by the Secretary under subsubsubparagraph (A); or

(C)       in a form, prepared by means of a computer, approved in writing for the purpose by the Secretary and in the format approved in writing by the Secretary; or

(D)       by a method approved in writing by the Secretary; or

(ii)        by submitting the prescription by giving the Medicare Australia CEO by telephone, details of the prescription which has been prepared and signed by the medical practitioner in accordance with subsubparagraph (i); or

(iii)       where the medical practitioner has attempted to obtain an authorisation by submitting details of the prescription to the Medicare Australia CEO in accordance with subsubparagraph (ii) but has been unable to do so because of a failure or other form of unavailability in the telephone system established by the Medicare Australia CEO for the provision of such authorisations, by submitting the prescription in accordance with the instructions stipulated in an emergency telephone message provided to the medical practitioner by the Medicare Australia CEO; or

(iv)      by submitting the prescription by giving the Medicare Australia CEO, by means of an electronic communication of a kind approved in writing by the Medicare Australia CEO, details of the prescription which has been prepared and signed by the medical practitioner in accordance with subsubparagraph (i).

11A.    For the purposes of subsubparagraph 11(d)(i), a prescription that has been prepared and signed by the medical practitioner in accordance with that subparagraph is taken to have been submitted by him or her if it is submitted by one of his or her employees.

12.        Subject to paragraph 12B, the authorisation of a prescription submitted under subparagraph 11(d) may be made:

(a)        if the prescription was submitted in accordance with subsubparagraph 11(d)(i) — by the Medicare Australia CEO signing his or her authorisation of the prescription on it and:

(i)         if the Medicare Australia CEO requires the medical practitioner to alter the prescription — by returning it to the medical practitioner for alteration before the medical practitioner gives it to the person in respect of whom it was prepared; or

(ii)        in any other case:

(A)       by returning it to the medical practitioner; or

(B)       by sending it to the person in respect of whom it was prepared; or

(b)        if the prescription was submitted in accordance with subsubparagraph 11(d)(ii) — orally, at the time the Medicare Australia CEO is given details of the prescription; or

(c)        if the prescription was submitted in accordance with subsubparagraph 11(d)(iv) — by the Medicare Australia CEO sending his or her authorisation, by electronic communication, to the medical practitioner.

12A.    If the Medicare Australia CEO authorises a prescription in accordance with subparagraph 12(b) or (c):

(a)        the Medicare Australia CEO must tell the medical practitioner, orally or by electronic communication, the number that has been allotted to the authorised prescription; and

(b)        the medical practitioner must:

(i)         mark that number on the prescription; and

(ii)        retain a copy of the prescription for 1 year from the date on which the prescription was authorised.

12B.     Notwithstanding paragraph 12, if the prescription was submitted in accordance with subsubparagraph 11(d)(iii), authorisation shall be deemed to have been granted upon completion by the medical practitioner of the prescription in accordance with the instructions stipulated in the emergency telephone message provided to the medical practitioner by the Medicare Australia CEO.

12C.     Where a prescription is authorised, or deemed to be authorised, in accordance with paragraph 12, and an authorisation is also granted in accordance with subregulation 13(5) of the Regulations increasing the maximum quantity or number of units of the pharmaceutical benefit that may, in the prescription, be directed to be supplied on any one occasion, or the maximum number of occasions on which the supply of the pharmaceutical benefit may, in the prescription, be directed to be repeated, the authorisation in accordance with paragraph 12 is taken to be for the prescription of the increased quantity, number, or occasions, as the case may be.

13.        The following purposes are specified in relation to each pharmaceutical benefit the name of which is specified in Part 2 of the Third Schedule to these Determinations:

(a)        where a class of persons is specified in the column headed “Purposes” — that the pharmaceutical benefit is to be supplied for the treatment of a person included in that class of persons;

(b)        where a disease or condition is specified in the column headed “Purposes” —

(i)         if subsubparagraph (ii) does not apply — that the pharmaceutical benefit is to be supplied for the treatment of that disease or condition in relation to any person; or

(ii)        if the disease or condition is specified in relation to a specified class of persons — that the pharmaceutical benefit is to be supplied for the treatment of that disease or condition in a person included in that class of persons;

(c)        where a purpose is specified in the column headed “Purposes” — that the pharmaceutical benefit is to be supplied for that purpose.

14.        For the purposes of subsection 85(6) of the Act, the name of the manufacturer or the names of manufacturers denoted in accordance with the following table by letters appearing in the column headed “Brand” in the First, Second or Third Schedule to these Determinations in relation to a drug or medicinal preparation the name of which is specified in that Schedule is or are the brand or brands under which the drug or medicinal preparation may be supplied under Part VII of the Act as a pharmaceutical benefit:

Letters Manufacturer's Name Letters Manufacturer's Name
AB Abbott Australasia Pty Ltd AE AFT Pharmaceuticals Pty Limited
AF Alphapharm Pty Limited AG Allergan Australia Pty Ltd
AH Altana Pharma Pty Ltd AL Alphapharm Medical A Division of Alphapharm Pty Limited
AN Amgen Australia Pty Ltd AP AstraZeneca Pty Ltd
AQ Alcon Laboratories (Australia) Pty Ltd AS Aspen Pharmacare Australia Pty Ltd
AV Aventis Pharma Pty Limited AW Arrow Pharmaceuticals Pty Limited
AX Sanofi Pasteur Pty Limited BC Bristol Laboratories A Division of Bristol-Myers Squibb Australia Pty Ltd
BD Biogen Idec Australia Pty Ltd BF Bellwether Pharma Limited
BG Biochemie Australia A Division of Sandoz Pty Ltd BN Bayer Australia Limited
BP British Pharmaceuticals BQ Bristol-Myers Squibb Pharmaceuticals A Division of Bristol-Myers Squibb Australia Pty Ltd
BR B. Braun Australia Pty Ltd BU Bausch & Lomb Surgical A Division of Bausch & Lomb (Australia) Pty Ltd
BX Baxter Healthcare Pty Limited BY Boehringer Ingelheim Pty Limited
CF CNS Pharma Pty Ltd CH Chem mart Pty Limited
CO Chemists' Own Pty Ltd A member of Sigma Group of Companies CS CSL Limited
CX Contact Lens Centre Australia Pty Ltd DK Dakota Pharmaceuticals A Division of Sanofi-Synthelabo Australia Pty Limited
DN Digiland Pty Ltd DR DiaCare International Pty Ltd
DT DermaTech Laboratories Pty Ltd EO Ego Pharmaceuticals Pty Ltd
EP EpiPharm Pty Ltd ES EBOS Group Pty Ltd
EX Essex Laboratories FA F.H. Faulding & Co. Limited
FB Pierre Fabre Medicament Australia Pty Limited FL C. B. Fleet Co. (Aust.) Pty Ltd
FM Fawns and McAllan Pty Ltd A member of Sigma Group of Companies FP Ferring Pharmaceuticals Pty Ltd
FR Charles E. Frosst Division of Merck Sharp & Dohme (Australia) Pty Ltd GC GlaxoSmithKline Consumer Healthcare
GD General Diabetes Services GH Goldshield Healthcare (Australia) Pty Ltd
GK GlaxoSmithKline Australia Pty Ltd GM Genepharm Pty Ltd
GN Genepharm Australasia Limited GP GP Laboratories A Division of Pfizer Pty Limited
GX GenRx Pty Ltd HA Hamilton Laboratories Pty Ltd
HP Hoechst Division of Aventis Pharma Pty Limited HX Hexal Australia Pty Ltd
IQ Ioquin A Division of Alcon Laboratories (Australia) Pty Ltd IT InterPharma Pty Ltd
IZ Intensive Care Products Pty Ltd JC Janssen-Cilag Pty Ltd
JT Johnson & Johnson Pacific Pty Limited KN Knoll A Division of Abbott Australasia Pty Ltd
KR Kenral Division of Pharmacia Australia Pty Limited KY Key Pharmaceuticals Pty Ltd
LB Life Bioscience Pty Ltd LF Laboratoires Fournier S.A.
LM Link Medical Products Pty Ltd LN Lennon Healthcare A Division of Aspen Pharmacare Australia Pty Ltd
LU Lundbeck Australia Pty Ltd LY Eli Lilly Australia Pty Limited
MD Macarthur Research Division of Roche Products Pty Ltd ME Menley & James Division of GlaxoSmithKline Australia Pty Ltd
MF Mundipharma Pty Ltd MK Merck Sharp & Dohme (Australia) Pty Ltd
ML Marion Division of Aventis Pharma Pty Limited MM 3M Pharmaceuticals Australia Pty Ltd
MQ Merck Pharmaceuticals MS Abbott Diagnostics Division (MediSense Products)
MX Mayne Pharma Pty Ltd NA National Diagnostic Products (Aust) Pty Limited
NE Norgine Pty Limited NF FlexPen Products of Novo Nordisk Pharmaceuticals Pty Ltd
NI InnoLet Products of Novo Nordisk Pharmaceuticals Pty Ltd NL NovoLet Products of Novo Nordisk Pharmaceuticals Pty Ltd
NM Novartis Medicines A Division of Novartis Pharmaceuticals Australia Pty Ltd NO Novo Nordisk Pharmaceuticals Pty Ltd
NT Nestlé Australia Ltd NU Nutricia Australia Pty Limited
NV Novartis Pharmaceuticals Australia Pty Ltd OA Orphan Australia Pty Ltd
OR Organon (Australia) Pty Limited PC Pfizer Consumer Healthcare Pty Ltd
PD Parke Davis Pty Ltd PE Pacific EyeCare A Division of Allergan Australia Pty Ltd
PF Pfizer Pty Limited PH Pharmacia Australia Pty Limited
PK Pharmatel Fresenius Kabi Pty Ltd PL Pharmalab
PM PMC Pharma A Division of AstraZeneca Pty Ltd PP Petrus Pharmaceuticals Pty Ltd
PU Pharmacia & Upjohn Pty Limited PX Point of Care Diagnostics Australia Pty Ltd
QM Qualimed Division of Aventis Pharma Pty Limited RA Ranbaxy Australia Pty Limited
RC Reckitt Benckiser (Australia) Pty Limited RD Roche Diagnostics Australia Pty Ltd
RE Real-RL Division of GlaxoSmithKline Australia Pty Ltd RO Roche Products Pty Ltd
SB Scientific Hospital Supplies Australia Products SC Schering Pty Ltd Australian Subsidiary of Schering AG, Berlin
SE Servier Laboratories (Aust.) Pty Ltd SG Serono Australia Pty Ltd
SH Schering-Plough Pty Ltd SI Sigma Pharmaceuticals Pty Ltd
SJ Sharpe Laboratories Pty Ltd SL SBPA A Division of Sandoz Pty Ltd
SM Solvay Pharmaceuticals Division of Solvay Biosciences Pty Ltd SN Smith & Nephew Healthcare
SU Sauter Laboratories (Aust.) Pty Ltd SW Sanofi-Synthelabo Australia Pty Limited
SY Schering AG SZ Sandoz Pty Ltd
TM Technipro Marketing Pty Ltd TW Terry White Chemists
UC UCB Pharma A Division of UCB Australia Pty Ltd VF Vitaflo Australia Pty Ltd
VT Valeant Pharmaceuticals Australasia Pty Ltd WA Winthrop Pharmaceuticals Division of Sanofi-Aventis Australia Pty Limited
WF MedWatchDog Pty Limited WT Wyeth Consumer Healthcare Pty Ltd
WW Wm R. Warner WX Wyeth Australia Pty Limited
WY Wyeth Pharmaceuticals Division of Wyeth Australia Pty Limited ZP Spirit Pharmaceuticals Pty Ltd
Abciximab I.V. injection 10 mg in 5 mL vial Injection 3 .. LY
Acamprosate Calcium Tablet 333 mg (enteric coated) Oral 180 1 AF
Acarbose Tablet 50 mg Oral 90 5 BN
Tablet 100 mg Oral 90 5 BN
Acetazolamide Tablet 250 mg Oral 100 3 SI
Acetylcysteine Sodium Inhalation solution equivalent to 200 mg acetylcysteine per mL, 5 mL Inhalation 30 3 BQ
Aciclovir Tablet 200 mg Oral 50 .. AF, GK, GM, GX, HX
Tablet 800 mg Oral 35 .. AF, GK, GM, GX, HX
Eye ointment 30 mg per g, 4.5 g Application to the eye 1 .. GK
Acitretin Capsule 10 mg Oral 100 2 RO
Capsule 25 mg Oral 100 2 RO
Adalimumab Injection 40 mg in 0.8 mL pre-filled syringe Injection 2 3 AB
Adrenaline I.M. injection 150 micrograms in 0.3 mL single dose syringe auto-injector Injection 1 .. CS
I.M. injection 300 micrograms in 0.3 mL single dose syringe auto-injector Injection 1 .. CS
Adrenaline Acid Tartrate Injection equivalent to adrenaline 1 in 1,000, 1 mL Injection 5 1 AP
Albendazole Tablet 200 mg Oral 6 .. GK
Tablet 400 mg Oral 60 2 GK
Alendronate Sodium Tablet equivalent to 70 mg alendronic acid Oral 4 5 AW, MK
Tablet equivalent to 40 mg alendronic acid Oral 30 5 MK
Alendronate Sodium with Colecalciferol Tablet equivalent to 70 mg alendronic acid with 70 micrograms colecalciferol Oral 4 5 MK
"Alfaré" Oral powder 400 g Oral 8 5 NT
Allopurinol Tablet 100 mg Oral 200 2 AF, CH, FM, GX, HX, SI, TW
Tablet 300 mg Oral 60 2 AF, CH, FM, GX, HX, SI, TW
Alprazolam Tablet 250 micrograms Oral 50 .. AF, AW, HX, PH
Tablet 500 micrograms Oral 50 .. AF, AW, HX, PH
Tablet 1 mg Oral 50 2 AF, AW, CH, GM, GX, HX, PH, TW
Tablet 2 mg Oral 50 2 AF, AW, CH, GM, GX, HX, PH, TW
Aluminium Hydroxide - Dried with Magnesium Hydroxide Tablet 200 mg-200 mg Oral 200 5 PC, WW
Oral suspension 200 mg-200 mg per 5 mL, 500 mL Oral 2 5 PC, WW
Aluminium Hydroxide - Dried with Magnesium Trisilicate and Magnesium Hydroxide Oral suspension 250 mg-120 mg-120 mg per 5 mL, 500 mL Oral 2 5 FM
Amantadine Hydrochloride Capsule 100 mg Oral 100 5 NV
Amiloride Hydrochloride Tablet 5 mg Oral 100 1 AF
Aminoglutethimide Tablet 250 mg Oral 100 5 NV
Amiodarone Hydrochloride Tablet 100 mg Oral 30 5 AF, AW, GX, HX, SW
Tablet 200 mg Oral 30 5 AF, AW, CH, GX, HX, SW, TW
Amisulpride Tablet 100 mg Oral 30 5 SW
Tablet 200 mg Oral 60 5 SW
Tablet 400 mg Oral 60 5 SW
Oral solution 100 mg per mL, 60 mL Oral 2 5 SW
Amitriptyline Hydrochloride Tablet 10 mg Oral 50 2 AF
Tablet 25 mg Oral 50 2 AF
Tablet 50 mg Oral 50 2 AF
Amlodipine Besylate Tablet equivalent to 5 mg amlodipine Oral 30 5 PF
Tablet equivalent to 10 mg amlodipine Oral 30 5 PF
Amlodipine Besylate with Atorvastatin Calcium Tablet equivalent to 5 mg amlodipine with 10 mg atorvastatin Oral 30 5 PF
Tablet equivalent to 5 mg amlodipine with 20 mg atorvastatin Oral 30 5 PF
Tablet equivalent to 5 mg amlodipine with 40 mg atorvastatin Oral 30 5 PF
Tablet equivalent to 5 mg amlodipine with 80 mg atorvastatin Oral 30 5 PF
Tablet equivalent to 10 mg amlodipine with 10 mg atorvastatin Oral 30 5 PF
Tablet equivalent to 10 mg amlodipine with 20 mg atorvastatin Oral 30 5 PF
Tablet equivalent to 10 mg amlodipine with 40 mg atorvastatin Oral 30 5 PF
Tablet equivalent to 10 mg amlodipine with 80 mg atorvastatin Oral 30 5 PF
Amoxycillin Trihydrate Tablet, chewable, equivalent to 250 mg amoxycillin Oral 20 1 GK
Tablet equivalent to 1 g amoxycillin Oral 14 1 BG, GK, SZ
Capsule equivalent to 250 mg amoxycillin Oral 20 1 AF, CH, GK, GM, GX, HX, SI, TW
Capsule equivalent to 500 mg amoxycillin Oral 20 1 AF, CH, CS, GK, GM, GX, HX, SI, TW
Sachet containing oral powder equivalent to 3 g amoxycillin Oral 1 .. GK
Amoxycillin Trihydrate with Potassium Clavulanate Tablet equivalent to 500 mg amoxycillin-125 mg clavulanic acid Oral 10 1 AL, AW, GK, HX, ME, SL, SZ
Tablet equivalent to 875 mg amoxycillin-125 mg clavulanic acid Oral 10 1 AL, AW, CH, GK, GX, HX, ME, SL, SZ, TW
Amoxycillin Trihydrate with Potassium Clavulanate and Water - Purified BP Powder for oral suspension equivalent to 125 mg amoxycillin-31.25 mg clavulanic acid per 5 mL, 75 mL Oral 1 1 AL, GK, HX, ME
Powder for oral suspension equivalent to 400 mg amoxycillin-57 mg clavulanic acid per 5 mL, 60 mL Oral 1 1 AL, GK, HX, ME
Amoxycillin Trihydrate with Water - Purified BP Powder for paediatric oral drops equivalent to 100 mg amoxycillin per mL, 20 mL Oral 1 1 GK
Powder for oral suspension equivalent to 125 mg amoxycillin per 5 mL, 100 mL Oral 1 1 AF, CH, GK, GM, GX, HX, TW
Powder for oral suspension equivalent to 250 mg amoxycillin per 5 mL, 100 mL Oral 1 1 AF, CH, GK, GM, GX, HX, SI, TW
Powder for oral suspension equivalent to 500 mg amoxycillin per 5 mL, 100 mL Oral 1 1 SZ
Amphotericin Lozenge 10 mg Oral 20 1 BQ
Powder for injection 50 mg Injection 1 .. BQ
Ampicillin Sodium Powder for injection equivalent to 500 mg ampicillin Injection 5 1 GM, LN
Powder for injection equivalent to 1 g ampicillin Injection 5 1 AS, GM, LN
Ampicillin Trihydrate Capsule equivalent to 250 mg ampicillin Oral 24 1 AF
Capsule equivalent to 500 mg ampicillin Oral 24 .. AF
Anakinra Injection 100 mg in 0.67 mL single use pre-filled syringe Injection 28 3 AN
Anastrozole Tablet 1 mg Oral 30 5 AP
Anecortave Acetate Suspension for injection 15 mg in 0.5 mL Posterior juxtascleral injection 1 .. AQ
Apraclonidine Hydrochloride Eye drops equivalent to 5 mg apraclonidine per mL, 10 mL Application to the eye 1 2 AQ
Aprepitant Pack containing 1 capsule 125 mg and 2 capsules 80 mg Oral 1 .. MK
Aripiprazole Tablet 10 mg Oral 30 5 BQ
Tablet 15 mg Oral 30 5 BQ
Tablet 20 mg Oral 30 5 BQ
Tablet 30 mg Oral 30 5 BQ
Aspirin Tablet 100 mg Oral 112 1 FA, MX
Tablet, dispersible, 300 mg Oral 96 1 RC
Atenolol Tablet 50 mg Oral 30 5 AF, AP, CH, GM, GX, SI, SZ, TW
Atorvastatin Calcium Tablet equivalent to 10 mg atorvastatin Oral 30 5 PF
Tablet equivalent to 20 mg atorvastatin Oral 30 5 PF
Tablet equivalent to 40 mg atorvastatin Oral 30 5 PF
Tablet equivalent to 80 mg atorvastatin Oral 30 5 PF
Atovaquone Oral suspension 750 mg per 5 mL, 210 mL Oral 1 .. GK
Atropine Sulfate Injection 600 micrograms in 1 mL ampoule Injection 10 1 AP
Eye drops 10 mg per mL, 15 mL Application to the eye 1 2 SI
Auranofin Tablet 3 mg Oral 60 5 GH
Azathioprine Tablet 25 mg Oral 100 2 GK, HX
Tablet 50 mg Oral 100 2 AF, AW, GK, GM, GX, HX
Azithromycin Dihydrate Tablet equivalent to 500 mg azithromycin Oral 2 .. PF
Azithromycin Dihydrate with Water - Purified BP Powder for oral suspension equivalent to 200 mg azithromycin per 5 mL, 15 mL Oral 1 .. PF
Baclofen Tablet 10 mg Oral 100 5 AF, AW, CH, GM, GX, HX, NV, TW
Tablet 25 mg Oral 100 5 AF, AW, CH, GM, GX, HX, NV, TW
Balsalazide Sodium Capsule 750 mg Oral 180 5 PK
"BCG Immunotherapeutic" (Bacillus Calmette-Guérin/ Connaught strain) Single dose set comprising 1 vial powder for intravesical administration containing 6.6 to 19.2 x 108 CFU and 1 vial diluent 3 mL Intravesical administration 3 1 AV
"BCG-Tice" (Bacillus Calmette-Guérin/ Tice strain) Vial containing powder for intravesical administration approximately 5 x 108 CFU Intravesical administration 3 1 OR
Beclomethasone Dipropionate Pressurised inhalation 50 micrograms per dose, 200 doses (CFC-free formulation) Inhalation by mouth 1 5 MM
Pressurised inhalation 100 micrograms per dose, 200 doses (CFC-free formulation) Inhalation by mouth 1 5 MM
Pressurised inhalation in breath actuated device 50 micrograms per dose, 200 doses (CFC-free formulation) Inhalation by mouth 1 5 MM
Pressurised inhalation in breath actuated device 100 micrograms per dose, 200 doses (CFC-free formulation) Inhalation by mouth 1 5 MM
Benzathine Penicillin Injection 900 mg in 2 mL cartridge-needle unit (for use with Tubex Injector) Injection 1 .. AS
Powder for injection 900 mg Injection 1 .. AS
Benzhexol Hydrochloride Tablet 2 mg Oral 200 2 SI
Tablet 5 mg Oral 200 1 SI
Benztropine Mesylate Tablet 2 mg Oral 60 2 PL
Injection 2 mg in 2 mL ampoule Injection 5 .. MK
Benzydamine Hydrochloride Mouth and throat rinse 22.5 mg per 15 mL, 500 mL Oral application 1 1 MM
Benzylpenicillin Sodium Powder for injection equivalent to 600 mg benzylpenicillin Injection 10 1 CS
Powder for injection equivalent to 3 g benzylpenicillin Injection 10 .. CS
Betamethasone Acetate with Betamethasone Sodium Phosphate Injection 3 mg-3.9 mg in 1 mL ampoule Injection 5 .. SH
Betamethasone Dipropionate Cream equivalent to 500 micrograms betamethasone per g, 15 g Application 1 1 EX, SH
Ointment equivalent to 500 micrograms betamethasone per g, 15 g Application 1 1 EX, SH
Betamethasone Valerate Cream equivalent to 200 micrograms betamethasone per g, 100 g Application 2 .. EX, FM, SH, SI
Cream equivalent to 500 micrograms betamethasone per g, 15 g Application 1 1 FM, SI
Ointment equivalent to 200 micrograms betamethasone per g, 100 g Application 2 .. EX, SH
Ointment equivalent to 500 micrograms betamethasone per g, 15 g Application 1 1 FM, SI
Betaxolol Hydrochloride Eye drops, suspension, equivalent to 2.5 mg betaxolol per mL, 5 mL Application to the eye 1 5 AQ
Eye drops, solution, equivalent to 5 mg betaxolol per mL, 5 mL Application to the eye 1 5 AQ, IQ
Bethanechol Chloride Tablet 10 mg Oral 100 2 HA
Bicalutamide Tablet 50 mg Oral 28 5 AP
Bifonazole Cream 10 mg per g, 15 g Application 2 3 BN
Bimatoprost Eye drops 300 micrograms per mL, 3 mL Application to the eye 1 5 AG
Biperiden Hydrochloride Tablet 2 mg Oral 200 2 AB
Bisacodyl Tablet 5 mg Oral 200 2 AE, AS
Suppositories 10 mg, 10 Rectal 3 5 BY, PP
Suppositories 10 mg, 12 Rectal 3 4 FL, PP
Enemas 10 mg in 5 mL, 25 Rectal 1 2 AS
Bisoprolol Fumarate Tablet 2.5 mg Oral 28 5 AL
Tablet 5 mg Oral 28 5 AL
Tablet 10 mg Oral 28 5 AL
Bivalirudin Trifluoroacetate Powder for I.V. injection equivalent to 250 mg bivalirudin, vial Injection 1 .. CS
Bleomycin Sulfate with any determined brand of Sodium Chloride Injection Powder for injection 15,000 I.U. (with required solvent) Injection 10 .. BQ, MX, SI
Brimonidine Tartrate Eye drops 2 mg per mL, 5 mL Application to the eye 1 5 AG, PE
Brimonidine Tartrate with Timolol Maleate Eye drops 2 mg brimonidine tartrate with timolol maleate equivalent to 5 mg timolol per mL, 5 mL Application to the eye 1 5 AG
Brinzolamide Eye drops 10 mg per mL, 5 mL Application to the eye 1 5 AQ, IQ
Bromocriptine Mesylate Tablet equivalent to 2.5 mg bromocriptine Oral 30 .. AF, NV
Capsule equivalent to 5 mg bromocriptine Oral 60 5 AF, NV
Capsule equivalent to 10 mg bromocriptine Oral 100 5 AF, NV
Budesonide Nebuliser suspension 500 micrograms in 2 mL single dose units, 30 Inhalation 1 5 AP
Nebuliser suspension 1 mg in 2 mL single dose units, 30 Inhalation 1 5 AP
Powder for oral inhalation in breath actuated device 100 micrograms per dose, 200 doses Inhalation by mouth 1 5 AP
Powder for oral inhalation in breath actuated device 200 micrograms per dose, 200 doses Inhalation by mouth 1 5 AP
Powder for oral inhalation in breath actuated device 400 micrograms per dose, 200 doses Inhalation by mouth 1 5 AP
Budesonide with Eformoterol Fumarate Dihydrate Powder for oral inhalation in breath actuated device 100 micrograms-6 micrograms per dose, 120 doses Inhalation by mouth 1 5 AP
Powder for oral inhalation in breath actuated device 200 micrograms-6 micrograms per dose, 120 doses Inhalation by mouth 1 5 AP
Powder for oral inhalation in breath actuated devices 400 micrograms-12 micrograms per dose, 60 doses, 2 Inhalation by mouth 1 5 AP
Buprenorphine Transdermal patch 5 mg Transdermal 2 .. MF
Transdermal patch 10 mg Transdermal 2 .. MF
Transdermal patch 20 mg Transdermal 2 .. MF
Bupropion Hydrochloride Tablet 150 mg (sustained release) Oral 30 .. GK, HX, RE
Busulfan Tablet 2 mg Oral 100 .. GK
Cabergoline Tablet 500 micrograms Oral 2 .. PH
Tablet 1 mg Oral 30 5 PU
Tablet 2 mg Oral 30 5 PU
Tablet 4 mg Oral 30 5 PU
Calcipotriol Ointment 50 micrograms per g, 30 g Application 1 1 CS
Calcitriol Capsule 0.25 microgram Oral 100 3 AF, AL, AW, GM, GX, HX, RO
Calcium Carbonate Tablet, chewable, 1.25 g (equivalent to 500 mg calcium) Oral 120 1 MM
Tablet 1.5 g (equivalent to 600 mg calcium) Oral 120 1 WT
Calcium Citrate Tablet equivalent to 250 mg calcium Oral 120 1 KY
Calcium Folinate Tablet equivalent to 15 mg folinic acid Oral 10 .. MX
Injection equivalent to 50 mg folinic acid in 5 mL Injection 5 5 IT, MX, PF
Injection equivalent to 100 mg folinic acid in 10 mL Injection 10 1 IT, PF
Injection equivalent to 300 mg folinic acid in 30 mL Injection 4 1 MX
Candesartan Cilexetil Tablet 4 mg Oral 30 5 AP
Tablet 8 mg Oral 30 5 AP
Tablet 16 mg Oral 30 5 AP
Tablet 32 mg Oral 30 5 AP
Candesartan Cilexetil with Hydrochlorothiazide Tablet 16 mg-12.5 mg Oral 30 5 AP
Capecitabine Tablet 150 mg Oral 60 2 RO
Tablet 500 mg Oral 120 2 RO
"Caprilon" Oral powder 420 g Oral 8 5 SB
Captopril Tablet 12.5 mg Oral 90 5 AF, BQ, CH, FM, GM, GX, HX, TW
Tablet 25 mg Oral 90 5 AF, BQ, CH, FM, GM, GX, HX, TW
Tablet 50 mg Oral 90 5 AF, BQ, CH, FM, GM, GX, HX, TW
Oral solution 5 mg per mL, 95 mL Oral 1 5 BQ
Carbamazepine Tablet 100 mg Oral 200 2 BG, NV, SZ
Tablet 200 mg Oral 200 2 AF, BG, NV, SZ
Tablet 200 mg (controlled release) Oral 200 2 NV
Tablet 400 mg (controlled release) Oral 200 2 NV
Oral suspension 100 mg per 5 mL, 300 mL Oral 1 5 NV
Carbimazole Tablet 5 mg Oral 200 2 RO
"Carbohydrate Free Mixture" Oral powder 225 g Oral 24 5 SB
Carbomer 974 Ocular lubricating gel 3 mg per g, single dose units 0.5 g, 30 Application to the eye 3 5 AQ
Carbomer 980 Ocular lubricating gel 2 mg per g, 10 g Application to the eye 1 5 BU, NM, NV
Eye drops 2 mg per g, single dose units 0.6 mL, 30 Application to the eye 3 5 NV
Carboplatin Solution for I.V. injection 50 mg in 5 mL Injection 2 .. IT, MX, PU
Solution for I.V. injection 150 mg in 15 mL Injection 6 .. IT, MX, PU
Solution for I.V. injection 450 mg in 45 mL Injection 2 .. IT, MX, PU
Carmellose Sodium Eye drops 5 mg per mL, 15 mL Application to the eye 1 5 AG
Eye drops 10 mg per mL, 15 mL Application to the eye 1 5 AG
Eye drops 2.5 mg per mL, single dose units 0.6 mL, 24 Application to the eye 4 5 CX
Eye drops 5 mg per mL, single dose units 0.4 mL, 30 Application to the eye 3 5 AG
Eye drops 10 mg per mL, single dose units 0.4 mL, 30 Application to the eye 3 5 AG
Ocular lubricating gel 10 mg per mL, single dose units 0.6 mL, 28 Application to the eye 3 5 CX
Carmustine Implants 7.7 mg, 8 Intracranial 1 .. OA
Carvedilol Tablet 3.125 mg Oral 30 .. CH, GX, MD, RO, TW
Tablet 6.25 mg Oral 60 5 CH, GX, MD, RO, TW
Tablet 12.5 mg Oral 60 5 CH, GX, MD, RO, TW
Tablet 25 mg Oral 60 5 CH, GX, MD, RO, TW
Cefaclor Monohydrate Tablet (sustained release) equivalent to 375 mg cefaclor Oral 10 1 AF, AS, CH, GM, GX, LN, RA, TW
Cefaclor Monohydrate with Water - Purified BP Powder for oral suspension equivalent to 125 mg cefaclor per 5 mL, 100 mL Oral 1 1 AF, AS, AW, CH, GX, TW
Powder for oral suspension equivalent to 250 mg cefaclor per  5 mL, 75 mL Oral 1 1 AF, AS, AW, CH, GX, TW
Cefepime Hydrochloride with any determined brand of Sodium Chloride Injection Powder for injection equivalent to 1 g cefepime (with required solvent) Injection 10 .. BQ
Powder for injection equivalent to 2 g cefepime (with required solvent) Injection 10 .. BQ
Cefotaxime Sodium Powder for injection equivalent to 1 g cefotaxime Injection 10 .. MX, SZ
Powder for injection equivalent to 2 g cefotaxime Injection 10 .. MX, SZ
Ceftriaxone Sodium Powder for injection equivalent to 500 mg ceftriaxone Injection 1 .. IZ
Powder for injection equivalent to 1 g ceftriaxone Injection 5 .. IZ, MX, RO, SZ
Powder for injection equivalent to 2 g ceftriaxone Injection 5 .. IZ, MX, RO, SZ
Cefuroxime Axetil Tablet equivalent to 250 mg cefuroxime Oral 14 1 GK
Celecoxib Capsule 100 mg Oral 60 3 PH
Capsule 200 mg Oral 30 3 PH
Cephalexin Capsule 250 mg (anhydrous) Oral 20 1 AF, AS, CH, GM, GX, HX, LN, RA, TW
Capsule 500 mg (anhydrous) Oral 20 1 AF, AS, CH, GM, GX, HX, LN, RA, TW
Cephalexin with Water - Purified BP Granules for oral suspension 125 mg per 5 mL, 100 mL Oral 1 1 AF, AS, CH, GM, GX, LN, TW
Granules for oral suspension 250 mg per 5 mL, 100 mL Oral 1 1 AF, AS, CH, GM, GX, LN, TW
Cephalothin Sodium Powder for injection equivalent to 1 g cephalothin Injection 10 1 AS, MX
Cephazolin Sodium Powder for injection equivalent to 500 mg cephazolin Injection 10 .. MX
Powder for injection equivalent to 1 g cephazolin Injection 10 .. AS, MX, SZ
Chlorambucil Tablet 2 mg Oral 100 2 GK
Chloramphenicol Ear drops (aqueous) 5 mg per mL, 5 mL Application to the ear 1 2 PF
Eye drops 5 mg per mL, 10 mL Application to the eye 1 2 PF, SI
Eye ointment 10 mg per g, 4 g Application to the eye 1 .. PF, SI
Chlorpromazine Hydrochloride Tablet 10 mg Oral 100 5 AV
Tablet 25 mg Oral 100 5 AV
Tablet 100 mg Oral 100 5 AV
Oral solution 25 mg per 5 mL, 100 mL Oral 1 5 AV
Injection 50 mg in 2 mL ampoule Injection 10 .. AV
Chlorthalidone Tablet 25 mg Oral 100 1 NV
Cholestyramine Sachets containing 4.7 g oral powder (equivalent to 4 g cholestyramine), 50 Oral 2 5 BQ
Sachets containing 9.4 g oral powder (equivalent to 8 g cholestyramine), 50 Oral 1 5 BQ
Chorionic Gonadotrophin Injection set containing 3 ampoules powder for injection 500 units and 3 ampoules solvent 1 mL Injection 1 5 OR
Injection set containing 3 ampoules powder for injection 1,500 units and 3 ampoules solvent 1 mL Injection 1 5 OR
Ciclesonide Pressurised inhalation 80 micrograms per dose, 120 doses (CFC-free formulation) Inhalation by mouth 1 5 AH
Pressurised inhalation 160 micrograms per dose, 120 doses (CFC-free formulation) Inhalation by mouth 1 5 AH
Cimetidine Tablet 200 mg Oral 120 5 AF, GK
Tablet 400 mg Oral 60 5 AF, GK, GX
Tablet 800 mg Oral 30 5 AF, GX
Ciprofloxacin Hydrochloride Tablet equivalent to 500 mg ciprofloxacin Oral 14 .. AL, AW, BF, BG, BN, GM, GN, GX, HX
Tablet equivalent to 750 mg ciprofloxacin Oral 14 .. AL, AW, BF, BN, GM, GN, GX, HX
Tablet equivalent to 250 mg ciprofloxacin Oral 2 .. BN
Ear drops equivalent to 3 mg ciprofloxacin per mL, 5 mL Application to the ear 1 1 AQ
Eye drops equivalent to 3 mg ciprofloxacin per mL, 5 mL Application to the eye 2 .. AQ, IQ
Cisplatin I.V. injection 10 mg in 10 mL Injection 1 .. PU
I.V. injection 50 mg in 50 mL Injection 1 .. MX, PU
I.V. injection 100 mg in 100 mL Injection 1 .. IT, MX
Citalopram Hydrobromide Tablet equivalent to 10 mg citalopram Oral 28 5 AF
Tablet equivalent to 20 mg citalopram Oral 28 5 AF, AW, CH, GM, GX, LU, RE, SL, SZ, TW
Tablet equivalent to 40 mg citalopram Oral 28 5 AF, GX, SZ
Cladribine Injection 10 mg in 5 mL vial Injection 7 .. OA
Solution for I.V. infusion 10 mg in 10 mL single use vial Injection 7 .. JC
Clarithromycin Tablet 250 mg Oral 14 1 AB, AF, AW, CH, GM, GX, HX, TW
Clindamycin Hydrochloride Capsule equivalent to 150 mg clindamycin Oral 25 .. KR, PH
Clomiphene Citrate Tablet 50 mg Oral 10 5 AV, AW, GX, HX, SG
Clomipramine Hydrochloride Tablet 25 mg Oral 50 2 AF, CH, GX, NV, TW
Clonazepam Tablet 500 micrograms Oral 200 2 AF, RO
Tablet 2 mg Oral 200 2 AF, RO
Oral liquid 2.5 mg per mL, 10 mL Oral 2 .. RO
Injection 1 mg in 2 mL (set containing solution 1 mg in 1 mL and 1 mL diluent) Injection 5 .. RO
Clonidine Hydrochloride Tablet 100 micrograms Oral 100 5 BY
Tablet 150 micrograms Oral 100 5 BY
Clopidogrel Hydrogen Sulfate Tablet equivalent to 75 mg clopidogrel Oral 28 5 BQ, SW
Clotrimazole Lotion 10 mg per mL, 20 mL Application 2 3 BN
Coal Tar - Prepared Gel 10 mg per g, 100 mL Application 1 2 EP
Codeine Phosphate Tablet 30 mg Oral 20 .. FM
Codeine Phosphate with Paracetamol Tablet 30 mg-500 mg Oral 20 .. AL, CO, DK, FM, GK, SW
Colchicine Tablet 500 micrograms Oral 100 2 AS, LN
Colestipol Hydrochloride Oral powder, sachets 5 g, 120 Oral 1 5 PH
Copper Sulfate Tablets, diagnostic compound, 36 2 3 BN
Cortisone Acetate Tablet 5 mg Oral 50 4 AS
Tablet 25 mg Oral 60 4 AS
Cyclophosphamide Tablet 50 mg Oral 50 2 PH
Cyclophosphamide with any determined brand of Sodium Chloride Injection  Powder for injection 500 mg (anhydrous) (with required solvent) Injection 2 .. BX
Powder for injection 1 g (anhydrous) (with required solvent) Injection 1 .. BX
Powder for injection 2 g (anhydrous) (with required solvent) Injection 1 .. BX
Cyclosporin Capsule 10 mg Oral 120 3 NV
Capsule 25 mg Oral 60 3 HX, NV
Capsule 50 mg Oral 60 3 HX, NV
Capsule 100 mg Oral 60 3 HX, NV
Oral liquid 100 mg per mL, 50 mL Oral 2 3 NV
Cyproheptadine Hydrochloride Tablet 4 mg (anhydrous) Oral 100 2 FR
Cyproterone Acetate Tablet 50 mg Oral 20 5 AF, GM, GX, HX, SC, SY
Tablet 100 mg Oral 50 5 GM, GX, HX, SC, SY
Cytarabine Injection 100 mg in 5 mL vial Injection 10 1 PU
Dalteparin Sodium Injection 2,500 I.U. (anti-Xa) in 0.2 mL single dose pre-filled syringe Injection 10 1 PH
Injection 5,000 I.U. (anti-Xa) in 0.2 mL single dose pre-filled syringe Injection 10 1 PH
Injection 7,500 I.U. (anti-Xa) in 0.75 mL single dose pre-filled syringe Injection 10 1 PH
Injection 10,000 I.U. (anti-Xa) in 1 mL single dose pre-filled syringe Injection 10 1 PH
Danazol Capsule 100 mg Oral 100 5 AF
Capsule 200 mg Oral 100 5 AF
Dantrolene Sodium Capsule 25 mg Oral 100 2 PU
Capsule 50 mg Oral 100 2 PU
Dapsone Tablet 25 mg Oral 100 1 LM
Tablet 100 mg Oral 100 1 LM
Desmopressin Acetate Intranasal solution 100 micrograms per mL, 2.5 mL dropper bottle Nasal 5 5 FP
Tablet 200 micrograms Oral 30 5 FP
Nasal spray (pump pack) 10 micrograms per actuation, 60 actuations, 6 mL Nasal 1 5 FP
Dexamethasone Tablet 500 micrograms Oral 30 4 AS
Tablet 4 mg Oral 30 4 AS
Eye drops 1 mg per mL, 5 mL Application to the eye 1 2 AQ
Dexamethasone Sodium Metasulfobenzoate with Framycetin Sulfate and Gramicidin Ear drops 500 micrograms (dexamethasone)-5 mg-50 micrograms per mL, 8 mL Application to the ear 1 2 AV, QM
Dexamethasone Sodium Phosphate Injection equivalent to 4 mg dexamethasone phosphate in 1 mL ampoule Injection 5 .. MX
Injection equivalent to 8 mg dexamethasone phosphate in 2 mL vial Injection 5 1 MX
Injection equivalent to 120 mg dexamethasone phosphate in 5 mL vial Injection 1 .. MX
Dexamphetamine Sulfate Tablet 5 mg Oral 100 5 SI
"Dialamine" Oral powder 200 g Oral 10 5 SB
Diazepam Tablet 2 mg Oral 50 .. AF, AW, RO, SU
Tablet 5 mg Oral 50 .. AF, AW, GM, RO, SU
Injection 10 mg in 2 mL ampoule Injection 5 .. MX
Diclofenac Sodium Tablet 25 mg (enteric coated) Oral 100 3 AF, AW, BG, CH, GM, GX, HX, NV, TW
Tablet 50 mg (enteric coated) Oral 50 3 AF, AW, CH, GM, GX, HX, NV, TW
Suppository 100 mg Rectal 40 3 NV
Dicloxacillin Sodium Capsule equivalent to 250 mg dicloxacillin Oral 24 .. AF, BQ, SI
Capsule equivalent to 500 mg dicloxacillin Oral 24 .. AF, BQ, SI
Powder for injection equivalent to 500 mg dicloxacillin Injection 5 .. BQ
Powder for injection equivalent to 1 g dicloxacillin Injection 5 1 BQ
"Digestelact" Oral powder 900 g Oral 3 1 SJ
Digoxin Tablet 62.5 micrograms Oral 200 1 FM, SI
Tablet 250 micrograms Oral 100 1 FM, SI
Paediatric oral solution 50 micrograms per mL, 60 mL Oral 2 3 SI
Dihydroergotamine Mesylate Injection 1 mg in 1 mL ampoule Injection 5 .. NV
Diltiazem Hydrochloride Tablet 60 mg Oral 90 5 AF, AV, CH, GM, GX, HP, HX, TW
Capsule 180 mg (controlled delivery) Oral 30 5 AV, CH, GM, GX, HP, TW
Capsule 240 mg (controlled delivery) Oral 30 5 AV, CH, GM, GX, HP, TW
Capsule 360 mg (controlled delivery) Oral 30 5 AV, HP
Diphenoxylate Hydrochloride with Atropine Sulfate Tablet 2.5 mg-25 micrograms Oral 20 .. KR, PH
Diphtheria and Tetanus Vaccine - Adsorbed Injection 0.5 mL ampoule Injection 3 .. CS
Diphtheria and Tetanus Vaccine - Adsorbed (Diluted) Injection 0.5 mL in pre-filled syringe Injection 5 .. CS
Dipivefrine Hydrochloride Eye drops 1 mg per mL, 10 mL Application to the eye 1 5 AG
Dipyridamole Capsule 200 mg (sustained release) Oral 60 5 BY
Dipyridamole with Aspirin Capsule 200 mg (sustained release)-25 mg Oral 60 5 BY
Disodium Etidronate Tablet 200 mg Oral 60 5 PU
Disodium Etidronate and Calcium Carbonate Pack containing 28 tablets disodium etidronate 200 mg and 76 tablets calcium carbonate 1.25 g (equivalent to 500 mg calcium) Oral 1 1 PU
Disodium Pamidronate Concentrated injection 15 mg in 5 mL vial Injection 4 .. MX
Injection set containing 4 vials powder for I.V. infusion 15 mg and 4 ampoules solvent 5 mL Injection 1 .. NV
Concentrated injection 30 mg in 10 mL vial Injection 2 .. MX
Injection set containing 2 vials powder for I.V. infusion 30 mg and 2 ampoules solvent 10 mL Injection 1 .. NV
Concentrated injection 60 mg in 10 mL vial Injection 1 .. MX
Disopyramide Capsule 100 mg Oral 100 5 AV
Capsule 150 mg Oral 100 5 AV
Docetaxel Injection set containing 1 single use vial concentrate for I.V. infusion 20 mg (anhydrous) in 0.5 mL and 1 single use vial solvent 1.5 mL Injection 2 .. AV
Injection set containing 1 single use vial concentrate for I.V. infusion 80 mg (anhydrous) in 2 mL and 1 single use vial solvent 6 mL Injection 1 .. AV
Dolasetron Mesylate Tablet 200 mg Oral 2 .. AV
I.V. injection 100 mg in 5 mL ampoule Injection 1 .. AV
Domperidone Tablet 10 mg Oral 25 .. JC
Donepezil Hydrochloride Tablet 5 mg Oral 28 5 PF
Tablet 10 mg Oral 28 5 PF
Dorzolamide Hydrochloride Eye drops equivalent to 20 mg dorzolamide per mL, 5 mL Application to the eye 1 5 MK
Dorzolamide Hydrochloride with Timolol Maleate Eye drops equivalent to 20 mg dorzolamide-5 mg timolol per mL, 5 mL Application to the eye 1 5 MK
Dothiepin Hydrochloride Capsule 25 mg Oral 50 2 AB, AF
Tablet 75 mg Oral 30 2 AB, AF
Doxepin Hydrochloride Tablet equivalent to 50 mg doxepin Oral 50 2 AF
Capsule equivalent to 10 mg doxepin Oral 50 2 AF, PF
Capsule equivalent to 25 mg doxepin Oral 50 2 AF, PF
Doxorubicin Hydrochloride Solution for I.V. injection or intravesical administration 10 mg in 5 mL single dose vial Injection or intravesical administration 4 .. IT, MX, PH
Solution for I.V. injection or intravesical administration 20 mg in 10 mL single dose vial Injection or intravesical administration 4 .. PH
Solution for I.V. injection or intravesical administration 50 mg in 25 mL single dose vial Injection or intravesical administration 3 .. IT, MX, PH
Solution for I.V. injection or intravesical administration 100 mg in 50 mL single dose vial Injection or intravesical administration 1 .. IT
Solution for I.V. injection or intravesical administration 200 mg in 100 mL single dose vial Injection or intravesical administration 1 .. IT
Doxorubicin Hydrochloride - Pegylated Liposomal Suspension for I.V. infusion 20 mg in 10 mL vial Injection 1 .. SH
Suspension for I.V. infusion 50 mg in 25 mL vial Injection 1 .. SH
Doxycycline Hydrochloride Tablet equivalent to 50 mg doxycycline Oral 25 5 AF, GM, PF
Capsule equivalent to 50 mg doxycycline (containing enteric coated pellets) Oral 25 5 FA, MX
Tablet equivalent to 100 mg doxycycline Oral 7 1 AF, GM, PF, SI
Capsule equivalent to 100 mg doxycycline (containing enteric coated pellets) Oral 7 1 FA, MX
Doxycycline Monohydrate Tablet equivalent to 50 mg doxycycline Oral 25 5 AW, CH, GX, SZ, TW
Tablet equivalent to 100 mg doxycycline Oral 7 1 CH, GX, SZ, TW
Drotrecogin Alfa (activated) Powder for I.V. infusion 5 mg, vial Injection 1 .. LY
Powder for I.V. infusion 20 mg, vial Injection 1 .. LY
"Duocal" Oral powder 400 g Oral 8 5 SB
Dydrogesterone Tablet 10 mg Oral 28 2 SM
"Easiphen" Oral liquid 250 mL Oral 90 5 SB
Efalizumab Injection set containing 4 vials powder for injection 125 mg and 4 pre-filled syringes diluent 1.3 mL Injection 1 3 SG
Eformoterol Fumarate Dihydrate Capsule containing powder for oral inhalation 12 micrograms (for use in Foradile Aerolizer) Inhalation by mouth 60 5 NV
Powder for oral inhalation in breath actuated device 6 micrograms per dose, 60 doses Inhalation by mouth 1 5 AP
Powder for oral inhalation in breath actuated device 12 micrograms per dose, 60 doses Inhalation by mouth 1 5 AP
"EleCare" Oral powder 400 g Oral 8 5 AB
Enalapril Maleate Tablet 5 mg Oral 30 5 AF, BF, CH, GM, GX, HX, MK, SI, SL, TW
Tablet 10 mg Oral 30 5 AF, BF, CH, FR, GM, GX, HX, MK, SI, SL, TW
Tablet 20 mg Oral 30 5 AF, BF, CH, FR, GM, GX, HX, MK, SI, SL, TW
Enalapril Maleate with Hydrochlorothiazide Tablet 20 mg-6 mg Oral 30 5 MK
"Energivit" Oral powder 400 g Oral 8 5 SB
Enoxaparin Sodium Injection 20 mg (2,000 I.U. anti-Xa) in 0.2 mL pre-filled syringe Injection 10 1 AV
Injection 40 mg (4,000 I.U. anti-Xa) in 0.4 mL pre-filled syringe Injection 10 1 AV
Injection 60 mg (6,000 I.U. anti-Xa) in 0.6 mL pre-filled syringe Injection 10 1 AV
Injection 80 mg (8,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe Injection 10 1 AV
Injection 100 mg (10,000 I.U. anti-Xa) in 1 mL pre-filled syringe Injection 10 1 AV
Entacapone Tablet 200 mg Oral 200 4 NV
Epirubicin Hydrochloride Solution for injection 10 mg in 5 mL Injection or intravesical administration 4 .. IT, PH
Solution for injection 20 mg in 10 mL Injection or intravesical administration 4 .. PH
Solution for injection 50 mg in 25 mL Injection or intravesical administration 4 .. IT, PH
Powder for injection 50 mg Injection or intravesical administration 4 .. MX
Solution for injection 100 mg in 50 mL Injection or intravesical administration 2 .. IT
Solution for injection 200 mg in 100 mL Injection or intravesical administration 1 .. IT
Eplerenone Tablet 25 mg Oral 30 5 PF
Tablet 50 mg Oral 30 5 PF
Eprosartan Mesylate Tablet equivalent to 400 mg eprosartan Oral 56 5 SM
Tablet equivalent to 600 mg eprosartan Oral 28 5 SM
Eprosartan Mesylate with Hydrochlorothiazide Tablet equivalent to 600 mg eprosartan with 12.5 mg hydrochlorothiazide Oral 28 5 SM
Eptifibatide Acetate Solution for I.V. injection equivalent to 20 mg eptifibatide in 10 mL vial Injection 2 .. SH
Solution for I.V. infusion equivalent to 75 mg eptifibatide in 100 mL vial Injection 3 .. SH
Erythromycin Capsule 250 mg (containing enteric coated pellets) Oral 25 1 FA, MX
Erythromycin Ethyl Succinate Tablet equivalent to 400 mg erythromycin Oral 25 1 AB, AF
Erythromycin Ethyl Succinate with Water - Purified BP Powder for oral liquid equivalent to 200 mg erythromycin per 5 mL, 100 mL Oral 1 1 AB, AF
Powder for oral liquid equivalent to 400 mg erythromycin per 5 mL, 100 mL Oral 1 1 AB, AF
Erythromycin Lactobionate Powder for I.V. infusion equivalent to 1 g erythromycin, vial Injection 5 .. AB
Escitalopram Oxalate Tablet equivalent to 10 mg escitalopram Oral 28 5 CF, LU
Tablet equivalent to 20 mg escitalopram Oral 28 5 CF, LU
Oral solution equivalent to 10 mg escitalopram per mL, 28 mL Oral 1 5 LU
Esomeprazole Magnesium Trihydrate Tablet (enteric coated), equivalent to 20 mg esomeprazole Oral 30 1 AP
Tablet (enteric coated), equivalent to 40 mg esomeprazole Oral 30 1 AP
Esomeprazole Magnesium Trihydrate and Clarithromycin and Amoxycillin Trihydrate Pack containing 14 tablets (enteric coated) esomeprazole magnesium trihydrate equivalent to 20 mg esomeprazole, 14 tablets clarithromycin 500 mg and 28 capsules amoxycillin trihydrate equivalent to 500 mg amoxycillin Oral 1 .. AP
Etanercept Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL Injection 2 2 WY
Injection set containing 4 vials powder for injection 50 mg and 4 pre-filled syringes solvent 1 mL Injection 1 2 WY
Ethacrynic Acid Tablet 25 mg Oral 200 1 MK
Ethosuximide Capsule 250 mg Oral 200 2 PF
Oral solution 250 mg per 5 mL, 200 mL Oral 1 5 PF
Etonogestrel Subcutaneous implant 68 mg Subcutaneous implantation 1 .. OR
Etoposide Capsule 50 mg Oral 20 .. BQ
Capsule 100 mg Oral 10 .. BQ
Solution for I.V. infusion 100 mg in 5 mL vial Injection 5 .. IT, MX
Etoposide Phosphate Powder for I.V. infusion 113.6 mg, vial Injection 5 .. BQ
Powder for I.V. infusion 1.136 g, vial Injection 1 .. BQ
Everolimus Tablet 0.25 mg Oral 60 3 NV
Tablet 0.5 mg Oral 60 3 NV
Tablet 0.75 mg Oral 120 3 NV
Exemestane Tablet 25 mg Oral 30 5 PH
Ezetimibe Tablet 10 mg Oral 30 5 MK
Ezetimibe with Simvastatin Tablet 10 mg-40 mg Oral 30 5 MK
Tablet 10 mg-80 mg Oral 30 5 MK
Famciclovir Tablet 125 mg Oral 40 1 NV
Tablet 250 mg Oral 21 .. NV
Tablet 500 mg Oral 30 .. NV
Famotidine Tablet 20 mg Oral 60 5 AF, AW, CH, GM, GX, HX, MK, TW
Tablet 40 mg Oral 30 5 AF, AW, CH, GM, GX, HX, MK, TW
Felodipine Tablet 2.5 mg (extended release) Oral 30 5 AL, AP
Tablet 5 mg (extended release) Oral 30 5 AL, AP
Tablet 10 mg (extended release) Oral 30 5 AL, AP
Fenofibrate Tablet 48 mg Oral 60 5 LF
Tablet 145 mg Oral 30 5 LF
Fentanyl Transdermal patch 2.1 mg Transdermal 5 .. JC
Transdermal patch 4.2 mg Transdermal 5 .. JC
Transdermal patch 8.4 mg Transdermal 5 .. JC
Transdermal patch 12.6 mg Transdermal 5 .. JC
Transdermal patch 16.8 mg Transdermal 5 .. JC
Ferrous Fumarate with Folic Acid Tablet 310 mg (equivalent to 100 mg iron)-350 micrograms Oral 60 1 AE
Ferrous Sulfate Oral liquid 30 mg per mL, 250 mL Oral 1 2 AE
Flecainide Acetate Tablet 50 mg Oral 60 5 MM
Tablet 100 mg Oral 60 5 AF, MM
Flucloxacillin Magnesium with Water - Purified BP Powder for oral suspension equivalent to 125 mg flucloxacillin per 5 mL, 100 mL Oral 1 .. GK
Powder for oral suspension equivalent to 250 mg flucloxacillin per 5 mL, 100 mL Oral 1 .. CS, GK
Flucloxacillin Sodium Capsule equivalent to 250 mg flucloxacillin Oral 24 .. AF, CS, GK, SI
Capsule equivalent to 500 mg flucloxacillin Oral 24 .. AF, CS, GK, SI
Powder for injection equivalent to 500 mg flucloxacillin Injection 5 .. CS, GM
Powder for injection equivalent to 1 g flucloxacillin Injection 5 1 AS, CS, GM, MX
Fluconazole Capsule 50 mg Oral 28 5 AF, AW, HX, MX, PF, RA
Capsule 100 mg Oral 28 5 AF, HX, MX, PF, RA
Capsule 200 mg Oral 28 5 AF, AW, HX, MX, PF, RA
Solution for I.V. infusion 100 mg in 50 mL vial Injection 7 .. PF
Solution for I.V. infusion 200 mg in 100 mL vial Injection 7 ..
Fludrocortisone Acetate Tablet 100 micrograms Oral 200 1 BQ
Fluorometholone Eye drops 1 mg per mL, 5 mL Application to the eye 1 5 AG, AQ
Fluorometholone Acetate Eye drops 1 mg per mL, 5 mL Application to the eye 1 2 AQ
Fluorouracil Injection 500 mg in 10 mL Injection 10 .. IT, MX
Injection 1000 mg in 20 mL Injection 5 .. IT
Fluoxetine Hydrochloride Tablet, dispersible, equivalent to 20 mg fluoxetine Oral 28 5 AL, LY
Capsule equivalent to 20 mg fluoxetine Oral 28 5 AF, AL, BF, CH, GM, GX, HX, LY, SI, TW
Flupenthixol Decanoate Oily I.M. injection 20 mg in 1 mL ampoule Injection 5 .. LU
Oily I.M. injection 40 mg in 2 mL ampoule Injection 5 .. LU
Oily I.M. injection 100 mg in 1 mL ampoule Injection 5 .. LU
Fluphenazine Decanoate Injection 12.5 mg in 0.5 mL ampoule Injection 5 .. BQ
Injection 25 mg in 1 mL ampoule Injection 5 .. BQ
Injection 50 mg in 2 mL ampoule Injection 5 .. BQ
Flurbiprofen Sodium Eye drops 300 micrograms per mL, single dose units 0.4 mL, 5 Application to the eye 1 .. AG
Flutamide Tablet 250 mg Oral 100 5 AF, SH
Fluticasone Propionate Pressurised inhalation 50 micrograms per dose, 120 doses (CFC-free formulation) Inhalation by mouth 1 5 GK
Pressurised inhalation 125 micrograms per dose, 120 doses (CFC-free formulation) Inhalation by mouth 1 5 GK
Pressurised inhalation 250 micrograms per dose, 120 doses (CFC-free formulation) Inhalation by mouth 1 1 GK
Powder for oral inhalation in breath actuated device 100 micrograms per dose, 60 doses Inhalation by mouth 1 5 GK
Powder for oral inhalation in breath actuated device 250 micrograms per dose, 60 doses Inhalation by mouth 1 5 GK
Powder for oral inhalation in breath actuated device 500 micrograms per dose, 60 doses Inhalation by mouth 1 1 GK
Fluticasone Propionate with Salmeterol Xinafoate Pressurised inhalation 50 micrograms fluticasone propionate with salmeterol xinafoate equivalent to 25 micrograms salmeterol per dose, 120 doses (CFC-free formulation) Inhalation by mouth 1 5 GK
Pressurised inhalation 125 micrograms fluticasone propionate with salmeterol xinafoate equivalent to 25 micrograms salmeterol per dose, 120 doses (CFC-free formulation) Inhalation by mouth 1 5 GK
Pressurised inhalation 250 micrograms fluticasone propionate with salmeterol xinafoate equivalent to 25 micrograms salmeterol per dose, 120 doses (CFC-free formulation) Inhalation by mouth 1 5 GK
Powder for oral inhalation in breath actuated device 100 micrograms fluticasone propionate with salmeterol xinafoate equivalent to 50 micrograms salmeterol per dose, 60 doses Inhalation by mouth 1 5 GK
Powder for oral inhalation in breath actuated device 250 micrograms fluticasone propionate with salmeterol xinafoate equivalent to 50 micrograms salmeterol per dose, 60 doses Inhalation by mouth 1 5 GK
Powder for oral inhalation in breath actuated device 500 micrograms fluticasone propionate with salmeterol xinafoate equivalent to 50 micrograms salmeterol per dose, 60 doses Inhalation by mouth 1 5 GK
Fluvastatin Sodium Capsule equivalent to 20 mg fluvastatin Oral 28 5 NM, NV
Capsule equivalent to 40 mg fluvastatin Oral 28 5 NM, NV
Fluvoxamine Maleate Tablet 50 mg Oral 30 5 AL, AW, HX, SM
Tablet 100 mg Oral 30 5 AF, AW, HX, SM
Folic Acid Tablet 500 micrograms Oral 200 .. AF
Tablet 5 mg Oral 200 1 AF
Follitropin Alfa Injection set containing 1 vial powder for injection 75 I.U. and 1 pre-filled syringe solvent 1 mL Injection 5 5 SG
Injection set containing 10 vials powder for injection 75 I.U. and 10 pre-filled syringes solvent 1 mL Injection 1 5 SG
Injection 300 I.U. in 0.5 mL multi-dose cartridge Injection 3 5 SG
Injection set containing 1 vial powder for injection 450 I.U. and 1 pre-filled syringe solvent 1 mL Injection 3 5 SG
Injection 450 I.U. in 0.75 mL multi-dose cartridge Injection 3 5 SG
Injection 900 I.U. in 1.5 mL multi-dose cartridge Injection 2 5 SG
Injection set containing 1 vial powder for injection 1,050 I.U. and 1 pre-filled syringe solvent 2 mL Injection 1 5 SG
Follitropin Beta Solution for injection 300 I.U. in 0.36 mL multi-dose cartridge Injection 3 5 OR
Solution for injection 600 I.U. in 0.72 mL multi-dose cartridge Injection 2 5 OR
Solution for injection 900 I.U. in 1.08 mL multi-dose cartridge Injection 2 5 OR
Fondaparinux Sodium Injection 2.5 mg in 0.5 mL single dose pre-filled syringe Injection 7 .. GK
Fosinopril Sodium Tablet 10 mg Oral 30 5 AF, AW, BQ, GX
Tablet 20 mg Oral 30 5 AF, AW, BQ, GX
Fosinopril Sodium with Hydrochlorothiazide Tablet 10 mg-12.5 mg Oral 30 5 BQ
Tablet 20 mg-12.5 mg Oral 30 5 BQ
Fotemustine Powder for injection 208 mg with solvent Injection 1 4 SE
Framycetin Sulfate Eye or ear drops 5 mg per mL, 8 mL Application to the eye or ear 1 2 AV
Frusemide Tablet 20 mg Oral 100 1 AV, CH, FM, GM, GX, TW
Tablet 40 mg Oral 100 1 AF, AV, CH, FM, GM, GX, HX, TW
Tablet 500 mg Oral 50 3 FM
Oral solution 10 mg per mL, 30 mL Oral 1 3 AV
Injection 20 mg in 2 mL Injection 5 .. AV, HX
Gabapentin Capsule 100 mg Oral 100 5 AF, AW, MX, PF
Capsule 300 mg Oral 100 5 AF, AL, AW, GM, GX, HX, MX, PF
Capsule 400 mg Oral 100 5 AF, AL, AW, GM, GX, HX, MX, PF
Tablet 600 mg Oral 100 5 PF
Tablet 800 mg Oral 100 5 AF, AW, PF
Galantamine Hydrobromide Capsule (prolonged release) equivalent to 8 mg galantamine Oral 28 5 JC
Capsule (prolonged release) equivalent to 16 mg galantamine Oral 28 5 JC
Capsule (prolonged release) equivalent to 24 mg galantamine Oral 28 5 JC
Gefitinib Tablet 250 mg Oral 30 1 AP
Gelatin - Succinylated I.V. infusion 20 g per 500 mL, 500 mL Injection 3 .. BR
Gemcitabine Hydrochloride Powder for I.V. infusion equivalent to 200 mg gemcitabine Injection 4 2 LY
Powder for I.V. infusion equivalent to 1 g gemcitabine Injection 2 2 LY
Gemfibrozil Tablet 600 mg Oral 60 5 AF, CH, GM, GX, HX, PF, SI, TW
Gentamicin Sulfate Injection equivalent to 80 mg gentamicin in 2 mL ampoule Injection 10 1 MX, PU
Eye drops equivalent to 3 mg gentamicin per mL, 5 mL Application to the eye 1 2 AG
Gestrinone Capsule 2.5 mg Oral 8 5 AV
Glatiramer Acetate Injection 20 mg in 1 mL single dose pre-filled syringe Injection 28 5 AV
Glibenclamide Tablet 5 mg Oral 100 5 AF, AV
Gliclazide Tablet 30 mg (modified release) Oral 100 5 SE
Tablet 80 mg Oral 100 5 AF, AW, CH, GX, HX, SE, TW
Glimepiride Tablet 1 mg Oral 30 5 AF, AV, AW, ML, SZ
Tablet 2 mg Oral 30 5 AF, AV, AW, ML, SZ
Tablet 3 mg Oral 30 5 AF, AV, AW, ML, SZ
Tablet 4 mg Oral 30 5 AF, AV, AW, ML, SZ
Glipizide Tablet 5 mg Oral 100 5 AF, PH
Glucagon Hydrochloride Injection set containing 1 mg (1 I.U.) and 1 mL solvent in disposable syringe Injection 1 1 NO
Glucose I.V. infusion 278 mmol (anhydrous) per L, 1 L Injection 5 1 BX
Glucose and Ketone Indicator—Urine Reagent strips, 50 (Keto-Diabur-Test 5000) 2 2 RD
Reagent strips, 50 (Keto-Diastix) 2 2 BN
Glucose Indicator—Blood Electrode strips, 50 (Advantage II) 2 5 RD
Electrode strips, 50 (Ascensia Elite) 2 5 BN
Electrode strips, 50 (Freestyle Papillon) 2 5 MS
Electrode strips, 50 (Glucocard 01 Sensor) 2 5 DR
Electrode strips, 50 (GlucoCare) 2 5 DR
Electrode strips, 50 (GlucoCare Super Sensor) 2 5 DR
Electrode strips, 50 (GlucoMen Sensor) 2 5 GD
Electrode strips, 50 (MWD Pen Sensor Strips) 2 5 WF
Electrode strips, 50 (Omnitest EZ) 2 5 BR
Electrode strips, 50 (Omnitest Plus) 2 5 BR
Electrode strips, 50 (Touch-In Plus) 2 5 DN
Electrode strips, 50 (TrueTrack) 2 5 DR
Discs containing electrode sensors, 10 sensors per disc, 5 2 5 BN
Electrode strips, 100 (Optium glucose) 1 5 MS
Electrode strips, 100 (Precision Plus) 1 5 MS
Electrode strips, 100 (SofTact) 1 5 MS
Electrode strips, 100 (TrueSense) 1 5 MS
Reagent strips, 50 (Accu-Chek Active) 2 5 RD
Reagent strips, 50 (Accu-Chek Go) 2 5 RD
Reagent strips, 51 (Accu-Chek Integra) 2 5 RD
Reagent strips, 50 (Betachek) 2 5 NA
Reagent strips, 50 (CareSens) 2 5 LB
Reagent strips, 50 (Glucoflex-R) 2 5 NA
Reagent strips, 50 (Glucostix) 2 5 BN
Reagent strips, 50 (SensoCard) 2 5 PX
Glucose Indicator—Urine Reagent strips, 50 (Clinistix) 2 2 BN
Reagent strips, 50 (Diastix) 2 2 BN
Glucose with Sodium Chloride, Potassium Chloride and Sodium Acid Citrate Oral rehydration salts 3.56 g-470 mg-300 mg-530 mg per sachet, 10 Oral 1 .. AS, AV, CH, GM, TW
Glycerol Suppositories 700 mg, 12 Rectal 3 5 PP
Suppositories 1.4 g, 12 Rectal 3 5 PP
Suppositories 2.8 g, 12 Rectal 3 5 PP
Glyceryl Trinitrate Tablets 600 micrograms, 100 Oral 1 5 FM, SI
Buccal/sublingual spray (pump pack) 400 micrograms per dose, 200 doses Buccal/sublingual 1 5 AV
Transdermal patch 18 mg Transdermal 30 5 MM
Transdermal patch 25 mg Transdermal 30 5 NV
Transdermal patch 40 mg Transdermal 30 5 SH
Transdermal patch 36 mg Transdermal 30 5 MM
Transdermal patch 50 mg Transdermal 30 5 NV
Transdermal patch 80 mg Transdermal 30 5 SH
Transdermal patch 54 mg Transdermal 30 5 MM
Transdermal patch 120 mg Transdermal 30 5 SH
Goserelin Acetate Subcutaneous implant equivalent to 3.6 mg goserelin in pre-filled injection syringe Subcutaneous implantation 1 5 AP
Subcutaneous implant (long acting) equivalent to 10.8 mg goserelin in pre-filled injection syringe Subcutaneous implantation 1 1 AP
Goserelin Acetate and Bicalutamide Pack containing 1 subcutaneous implant equivalent to 3.6 mg goserelin in pre-filled injection syringe and 28 tablets bicalutamide 50 mg Subcutaneous implantation (implant) and oral (tablets) 1 5 AP
Pack containing 1 subcutaneous implant equivalent to 10.8 mg goserelin in pre-filled injection syringe and 28 tablets bicalutamide 50 mg Subcutaneous implantation (implant) and oral (tablets) 1 .. AP
Pack containing 1 subcutaneous implant equivalent to 10.8 mg goserelin in pre-filled injection syringe and 84 tablets bicalutamide 50 mg Subcutaneous implantation (implant) and oral (tablets) 1 1 AP
Granisetron Hydrochloride Tablet equivalent to 2 mg granisetron Oral 2 .. MX
Concentrated injection equivalent to 3 mg granisetron in 3 mL ampoule Injection 1 .. MX
Griseofulvin Tablet 125 mg Oral 100 2 SI
Tablet 500 mg Oral 28 2 SI
Haloperidol Tablet 500 micrograms Oral 100 5 SI
Tablet 1.5 mg Oral 100 5 SI
Tablet 5 mg Oral 50 5 SI
Oral solution 2 mg per mL, 100 mL Oral 1 5 SI
Injection 5 mg in 1 mL ampoule Injection 10 .. SI
Haloperidol Decanoate I.M. injection equivalent to 50 mg haloperidol in 1 mL ampoule Injection 5 .. JC
I.M. injection equivalent to 150 mg haloperidol in 3 mL ampoule Injection 5 .. JC
"HCU express" Sachets containing oral powder 25 g, 30 Oral 4 5 VF
"HCU gel" Sachets containing oral powder 20 g, 30 Oral 4 5 VF
Heparin Sodium Injection 5,000 units in 0.2 mL ampoule Injection 5 5 MX
Injection (preservative-free) 5,000 I.U. in 5 mL ampoule Injection 50 5 PU
Injection 35,000 units in 35 mL vial Injection 12 5 MX
Hexamine Hippurate Tablet 1 g Oral 100 5 MM
Homatropine Hydrobromide Eye drops 20 mg per mL, 15 mL Application to the eye 1 2 AQ
Hydralazine Hydrochloride Tablet 25 mg Oral 200 2 AF
Tablet 50 mg Oral 200 2 AF
Hydrochlorothiazide Tablet 25 mg Oral 100 1 PL
Hydrochlorothiazide with Amiloride Hydrochloride Tablet 50 mg-5 mg Oral 100 1 AF, MK
Hydrochlorothiazide with Triamterene Tablet 25 mg-50 mg Oral 100 1 AF
Hydrocortisone Tablet 4 mg Oral 50 4 AF
Tablet 20 mg Oral 60 4 AF
Cream 10 mg per g, 50 g Application 1 1 EO
Hydrocortisone Acetate Eye ointment 5 mg per g, 5 g Application to the eye 1 .. SI
Eye ointment 10 mg per g, 5 g Application to the eye 1 .. SI
Cream 10 mg per g, 30 g Application 1 1 FM, SI
Cream 10 mg per g, 50 g Application 1 1 DT, FM, SI
Ointment 10 mg per g, 30 g Application 1 1 FM, SI
Ointment 10 mg per g, 50 g Application 1 1 FM, SI
Rectal foam 90 mg per applicatorful, 14 applications, aerosol 21.1 g Rectal 2 3 GC
Hydrocortisone Sodium Succinate Injection equivalent to 100 mg hydrocortisone with 2 mL solvent Injection 2 .. PH
Injection equivalent to 250 mg hydrocortisone with 2 mL solvent Injection 1 .. PH
Hydromorphone Hydrochloride Tablet 2 mg Oral 20 .. AB
Tablet 4 mg Oral 20 .. AB
Tablet 8 mg Oral 20 .. AB
Oral liquid 1 mg per mL, 473 mL Oral 1 .. AB
Injection 2 mg in 1 mL ampoule Injection 5 .. AB
Injection 10 mg in 1 mL ampoule Injection 5 .. AB
Injection 50 mg in 5 mL ampoule Injection 5 .. AB
Injection 500 mg in 50 mL vial Injection 1 .. AB
Hydroxocobalamin Injection 1 mg in 1 mL ampoule Injection 2 .. MX
Injection 1 mg in 1 mL Injection 3 .. MX
Hydroxychloroquine Sulfate Tablet 200 mg Oral 100 1 SW
Hydroxyurea Capsule 500 mg Oral 100 .. BQ
Hypromellose Eye drops 3 mg per mL, 15 mL Application to the eye 1 5 NM, NV
Eye drops 5 mg per mL, 15 mL Application to the eye 1 5 AQ, SI
Hypromellose 2900 with Dextran 70 Eye drops 3 mg-1 mg per mL, single dose units 0.4 mL, 28 Application to the eye 3 5 AQ
Hypromellose 4500 with Dextran 70 Eye drops 3 mg-1 mg per mL, 15 mL Application to the eye 1 5 AQ, IQ
Hypromellose with Carbomer 980 Ocular lubricating gel 3 mg-2 mg per g, 10 g Application to the eye 1 5 NM, NV
Ibuprofen Tablet 200 mg Oral 100 3 AF
Tablet 400 mg Oral 30 .. AB
Idarubicin Hydrochloride Capsule 5 mg Oral 3 .. PH
Capsule 10 mg Oral 3 .. PH
Solution for I.V. injection 5 mg in 5 mL single use vial Injection 3 .. PH
Solution for I.V. injection 10 mg in 10 mL single use vial Injection 6 .. PH
Ifosfamide Powder for I.V. injection 1 g in single dose vial Injection 5 5 BX
Powder for I.V. injection 2 g in single dose vial Injection 5 5 BX
Imipramine Hydrochloride Tablet 10 mg Oral 50 2 LN, NV
Tablet 25 mg Oral 50 2 LN, NV
Imiquimod Cream 50 mg per g, 250 mg single use sachets, 12 Application 1 1 MM
Indapamide Hemihydrate Tablet 1.5 mg (sustained release) Oral 90 1 SE
Tablet 2.5 mg Oral 90 1 AF, CH, GM, GX, HX, SE, SI, TW
Indomethacin Capsule 25 mg Oral 100 3 AF, MK
Suppository 100 mg Rectal 40 3 MK
Influenza Vaccine (Split Virion) - Inactivated Injection containing antigens representative of the following types: A/New Caledonia/20/99 (H1N1)-like strain 15 micrograms haemagglutinin; A/Wisconsin/67/2005 (H3N2)-like strain 15 micrograms haemagglutinin; B/Malaysia/2506/2004-like strain 15 micrograms haemagglutinin; 0.5 mL pre-filled syringe Injection 1 .. AX, CS, GK, SM
Insect Allergen Extract—Honey Bee Venom Injection set containing 550 micrograms vial with 9 mL vial solvent and 3 vials diluent 1.8 mL Injection 1 .. ES
Insect Allergen Extract—Paper Wasp Venom Injection set containing 550 micrograms vial with 9 mL vial solvent and 3 vials diluent 1.8 mL Injection 1 .. ES
Insect Allergen Extract—Yellow Jacket Venom Injection set containing 550 micrograms vial with 9 mL vial solvent and 3 vials diluent 1.8 mL Injection 1 .. ES
Insulin Aspart Injection (human analogue) 100 units per mL, 10 mL vial Injection 5 2 NO
Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 Injection 5 1 NF, NO
Insulin Aspart with Insulin Aspart Protamine Suspension Injections (human analogue), cartridges, 30 units-70 units per mL, 3 mL, 5 Injection 5 1 NF, NO
Insulin Detemir Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 Injection 5 1 NF
Insulin Glargine Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 Injection 5 1 AV
Insulin - Isophane Injection (bovine) 100 units per mL, 10 mL vial Injection 5 2 AS
Injection (human) 100 units per mL, 10 mL vial Injection 5 2 LY, NO
Injections (human), cartridges, 100 units per mL, 3 mL, 5 Injection 5 1 LY, NI, NL, NO
Insulin Lispro Injection (human analogue) 100 units per mL, 10 mL vial Injection 5 2 LY
Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 Injection 5 1 LY
Insulin Lispro with Insulin Lispro Protamine Suspension Injections (human analogue), cartridges, 25 units-75 units per mL, 3 mL, 5 Injection 5 1 LY
Injections (human analogue), cartridges, 50 units-50 units per mL, 3 mL, 5 Injection 5 1 LY
Insulin - Neutral Injection (bovine) 100 units per mL, 10 mL vial Injection 5 2 AS
Injection (human) 100 units per mL, 10 mL vial Injection 5 2 LY, NO
Injections (human), cartridges, 100 units per mL, 3 mL, 5 Injection 5 1 LY, NO
Insulin - Neutral with Insulin - Isophane Injection (human) 30 units-70 units per mL, 10 mL vial Injection 5 2 LY, NO
Injection (human) 50 units-50 units per mL, 10 mL vial Injection 5 2 NO
Injections (human), cartridges, 20 units-80 units per mL, 3 mL, 5 Injection 5 1 NO
Injections (human), cartridges, 30 units-70 units per mL, 3 mL, 5 Injection 5 1 LY, NI, NO
Injections (human), cartridges, 50 units-50 units per mL, 3 mL, 5 Injection 5 1 NO
Interferon Alfa-2a Injection 3,000,000 I.U. in 0.5 mL single dose pre-filled syringe Injection 15 4 RO
Injection 4,500,000 I.U. in 0.5 mL single dose pre-filled syringe Injection 5 4 RO
Injection 6,000,000 I.U. in 0.5 mL single dose pre-filled syringe Injection 5 4 RO
Injection 9,000,000 I.U. in 0.5 mL single dose pre-filled syringe Injection 5 4 RO
Interferon Alfa-2b Solution for injection 18,000,000 I.U. in 1.2 mL multi-dose injection pen Injection 3 4 SH
Solution for injection 30,000,000 I.U. in 1.2 mL multi-dose injection pen Injection 3 5 SH
Interferon Beta-1a Injection set comprising 1 vial powder for injection 30 micrograms (6,000,000 I.U.) with diluent Injection 4 5 BD
Injection 30 micrograms (6,000,000 I.U.) in 0.5 mL single dose pre-filled syringe Injection 4 5 BD
Injection 44 micrograms (12,000,000 I.U.) in 0.5 mL single dose pre-filled syringe Injection 12 5 SG
Interferon Beta-1b Injection set comprising 1 vial powder for injection 8,000,000 I.U. (250 micrograms) and solvent Injection 15 5 SC
Ipratropium Bromide Pressurised inhalation 21 micrograms per dose, 200 doses (CFC-free formulation) Inhalation by mouth 2 5 BY
Nebuliser solution 250 micrograms (anhydrous) in 1 mL single dose units, 30 Inhalation 2 5 AF, AW, BY, CH, GM, GX, PU, TW
Nebuliser solution 500 micrograms (anhydrous) in 1 mL single dose units, 30 Inhalation 2 5 AF, AW, BY, CH, GM, GX, PU, TW
Nebuliser solution 250 micrograms (anhydrous) per mL, 20 mL Inhalation 2 2 BY
Irbesartan Tablet 75 mg Oral 30 5 BQ, SW
Tablet 150 mg Oral 30 5 BQ, SW
Tablet 300 mg Oral 30 5 BQ, SW
Irbesartan with Hydrochlorothiazide Tablet 150 mg-12.5 mg Oral 30 5 BQ, SW
Tablet 300 mg-12.5 mg Oral 30 5 BQ, SW
Irinotecan Hydrochloride Trihydrate I.V. injection 40 mg in 2 mL vial Injection 1 3 MX, PU
I.V. injection 100 mg in 5 mL vial Injection 2 3 MX, PU
Iron Polymaltose Complex Injection 100 mg (iron) in 2 mL ampoule Injection 5 .. AS, SI
Iron Sucrose Concentrate for solution for infusion 2.7 g (equivalent to 100 mg iron (III)) in 5 mL ampoule Injection 5 .. AS
Isoniazid Tablet 100 mg Oral 100 2 FM
Isosorbide Dinitrate Tablet 10 mg Oral 200 2 AF, SI
Tablet 5 mg (sublingual) Oral 200 2 SI
Isosorbide Mononitrate Tablet 60 mg (sustained release) Oral 30 5 AF, AP, CH, GM, GX, HX, PM, TW
Tablet 120 mg (sustained release) Oral 30 5 AP, PM
Isotretinoin Capsule 10 mg Oral 60 3 GM, GX, RO
Capsule 20 mg Oral 60 3 CH, GM, GX, HX, RO, TW
Capsule 40 mg Oral 30 3 GM
Itraconazole Capsule 100 mg Oral 60 5 JC
Ivermectin Tablet 3 mg Oral 4 .. MK
"Karicare De-Lact" Oral powder 900 g Oral 5 .. NU
Ketoconazole Tablet 200 mg Oral 10 .. JC
Cream 20 mg per g, 30 g Application 1 2 JC
Shampoo 10 mg per g, 100 mL Application 1 1 JC
Shampoo 20 mg per g, 60 mL Application 1 1 JC
"Ketonex-1" Oral powder 350 g Oral 8 5 AB
"Ketonex-2" Oral powder 325 g Oral 10 5 AB
Ketoprofen Capsule 200 mg (sustained release) Oral 28 3 AV, HP
Suppository 100 mg Rectal 40 3 AV
"Kindergen" Oral powder 400 g Oral 16 5 SB
Labetalol Hydrochloride Tablet 100 mg Oral 100 5 AF, SI
Tablet 200 mg Oral 100 5 AF, SI
Lactulose Solution BP 3.34 g per 5 mL, 500 mL Oral 1 5 AF, AW, GM, GX, HX, SM
Lamotrigine Tablet 5 mg Oral 56 5 AF, AW, GK, HX, ME
Tablet 25 mg Oral 56 5 AF, AW, GK, GM, GX, HX, ME, RA
Tablet 50 mg Oral 56 5 AF, AW, GK, GM, GX, HX, ME, RA
Tablet 100 mg Oral 56 5 AF, AW, GK, GM, GX, HX, ME, RA
Tablet 200 mg Oral 56 5 AF, AW, GK, GM, GX, HX, ME, RA
Lansoprazole Capsule 30 mg Oral 30 1 WY
Sachet containing granules for oral suspension, 30 mg per sachet Oral 28 1 WY
Capsule 15 mg Oral 30 5 WY
Latanoprost Eye drops 50 micrograms per mL, 2.5 mL Application to the eye 1 5 PU
Latanoprost with Timolol Maleate Eye drops 50 micrograms latanoprost with timolol maleate equivalent to 5 mg timolol per mL, 2.5 mL Application to the eye 1 5 PF
Leflunomide Pack containing 3 tablets leflunomide 100 mg and 30 tablets leflunomide 20 mg Oral 1 .. AV
Tablet 10 mg Oral 30 5 AV, HP
Tablet 20 mg Oral 30 5 AV, HP
Lercanidipine Hydrochloride Tablet 10 mg Oral 30 5 SM
Tablet 20 mg Oral 30 5 SM
Letrozole Tablet 2.5 mg Oral 30 5 NV
Leuprorelin Acetate I.M. injection (modified release), powder for injection 7.5 mg with diluent in pre-filled dual-chamber syringe Injection 1 5 AB
Suspension for subcutaneous injection (modified release), 7.5 mg injection set Injection 1 5 MX
I.M. injection (modified release), powder for injection 22.5 mg with diluent in pre-filled dual-chamber syringe Injection 1 1 AB
Suspension for subcutaneous injection (modified release), 22.5 mg injection set Injection 1 1 MX
I.M. injection (modified release), powder for injection 30 mg with diluent in pre-filled dual-chamber syringe Injection 1 1 AB
Suspension for subcutaneous injection (modified release), 30 mg injection set Injection 1 1 MX
Suspension for subcutaneous injection (modified release), 45 mg injection set Injection 1 .. MX
Levetiracetam Tablet 250 mg Oral 60 5 UC
Tablet 500 mg Oral 60 5 UC
Tablet 1 g Oral 60 5 UC
Levobunolol Hydrochloride Eye drops 2.5 mg per mL, 5 mL Application to the eye 1 5 AG
Levodopa with Benserazide Hydrochloride Dispersible tablet 50 mg-12.5 mg (benserazide) Oral 100 5 RO
Dispersible tablet 100 mg-25 mg (benserazide) Oral 100 5 RO
Tablet 100 mg-25 mg (benserazide) Oral 100 5 RO
Tablet 200 mg-50 mg (benserazide) Oral 100 5 RO
Capsule 50 mg-12.5 mg (benserazide) Oral 100 5 RO
Capsule 100 mg-25 mg (benserazide) Oral 100 5 RO
Capsule 100 mg-25 mg (benserazide) (sustained release) Oral 100 5 RO
Capsule 200 mg-50 mg (benserazide) Oral 100 5 RO
Levodopa with Carbidopa Tablet 200 mg-50 mg (anhydrous) (modified release) Oral 100 5 MK
Tablet 100 mg-25 mg (anhydrous) Oral 100 5 AF, MK
Tablet 250 mg-25 mg (anhydrous) Oral 100 5 HX, MK
Levodopa with Carbidopa and Entacapone Tablet 50 mg-12.5 mg-200 mg Oral 200 4 NV
Tablet 100 mg-25 mg-200 mg Oral 200 4 NV
Tablet 150 mg-37.5 mg-200 mg Oral 200 4 NV
Levonorgestrel Tablets 30 micrograms, 28 Oral 4 2 SC, WY
Intrauterine drug delivery system 52 mg Intrauterine 1 .. SC
Levonorgestrel with Ethinyloestradiol Pack containing 21 tablets 125 micrograms-50 micrograms and 7 inert tablets Oral 4 2 SC
Tablets 150 micrograms-30 micrograms, 21 Oral 4 2 SC
Pack containing 21 tablets 150 micrograms-30 micrograms and 7 inert tablets Oral 4 2 SC, SY, WX, WY
Pack containing 6 tablets 50 micrograms-30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-30 micrograms and 7 inert tablets Oral 4 2 SC, SY, WX, WY
Lignocaine Hydrochloride Injection 100 mg in 5 mL Injection 5 .. PF
Infusion 500 mg in 5 mL ampoule Injection 10 .. AP
Lincomycin Hydrochloride Injection equivalent to 600 mg lincomycin in 2 mL vial Injection 5 .. PH
Liothyronine Sodium Tablet 20 micrograms Oral 100 2 SI
Lisinopril Tablet 5 mg Oral 30 5 AF, AP, AW, BF, CH, GM, GX, HX, MK, TW
Tablet 10 mg Oral 30 5 AF, AP, AW, BF, CH, GM, GX, HX, MK, TW
Tablet 20 mg Oral 30 5 AF, AP, AW, BF, CH, GM, GX, HX, MK, TW
Lithium Carbonate Tablet 250 mg Oral 200 2 AS
Tablet 450 mg (slow release) Oral 200 2 GK
"Locasol" Low calcium compound powder 400 g Oral 8 5 NU
Loperamide Hydrochloride Capsule 2 mg Oral 12 .. AS, JC
"Lophlex" Sachets containing oral powder 27.8 g, 30 Oral 3 5 SB
"Lophlex LQ" Oral liquid 125 mL, 30 Oral 3 5 SB
Lumiracoxib Tablet 200 mg Oral 30 3 NV
Macrogol 3350 with Sodium Chloride, Sodium Bicarbonate and Potassium Chloride Sachets containing powder for oral solution 13.125 g-350.7 mg-178.5 mg-46.6 mg, 30 Oral 1 5 NE
"Mapleflex" Sachets containing oral powder 29 g, 30 Oral 4 5 SB
Medroxyprogesterone Acetate Tablet 500 mg Oral 30 2 PH
Tablet 100 mg Oral 100 2 PH
Tablet 200 mg Oral 60 2 PH
Tablet 250 mg Oral 60 2 PH
Tablet 5 mg Oral 56 2 KR, PH
Tablet 10 mg Oral 30 2 HX, KR, PH
Injection 50 mg in 1 mL vial Injection 1 1 PH
Injection 150 mg in 1 mL vial Injection 1 1 KR, PH
Mefenamic Acid Capsule 250 mg Oral 50 2 PD
Megestrol Acetate Tablet 160 mg Oral 30 2 BQ
Meloxicam Tablet 7.5 mg Oral 30 3 AW, BY
Tablet 15 mg Oral 30 3 AW, BY
Capsule 7.5 mg Oral 30 3 BY
Capsule 15 mg Oral 30 3 BY
Melphalan Tablet 2 mg Oral 25 1 GK
Mercaptopurine Tablet 50 mg Oral 100 2 GK
Mesalazine Tablet 250 mg (enteric coated) Oral 100 5 GK
Tablet 500 mg (enteric coated) Oral 100 5 OA
Sachet containing granules, 500 mg per sachet Oral 100 5 OA
Sachet containing granules, 1 g per sachet Oral 100 2 OA
Suppositories 1 g, 28 Rectal 1 .. FP
Enemas 1 g in 100 mL, 7 Rectal 4 .. FP
Enemas 2 g in 60 mL, 7 Rectal 4 .. OA
Enemas 4 g in 60 mL, 7 Rectal 4 .. OA
Rectal foam 1 g per applicatorful, 14 applications, aerosol 80 g Rectal 4 .. OA
Mesna Solution for I.V. injection 400 mg in 4 mL ampoule Injection 15 5 BX
Solution for I.V. injection 1 g in 10 mL ampoule Injection 15 5 BX
"Metabolic Mineral Mixture" Oral powder 250 g Oral 1 5 SB
Metformin Hydrochloride Tablet 500 mg Oral 100 5 AF, AL, AW, BF, CH, GM, GN, GX, HX, MQ, TW
Tablet 500 mg (extended release) Oral 90 5 AL
Tablet 850 mg Oral 60 5 AF, AL, AW, BF, CH, GM, GN, GX, HX, MQ, TW
Tablet 1 g Oral 90 5 AF, AL, AW
Metformin Hydrochloride with Glibenclamide Tablet 250 mg-1.25 mg Oral 90 5 AL
Tablet 500 mg-2.5 mg Oral 90 5 AL
Tablet 500 mg-5 mg Oral 90 5 AL
Methadone Hydrochloride Tablet 10 mg Oral 20 .. GK
Injection 10 mg in 1 mL ampoule Injection 5 .. GK
Methotrexate Tablet 2.5 mg Oral 30 5 MX, PH
Tablet 10 mg Oral 50 2 PH
Injection 5 mg in 2 mL vial Injection 5 .. MX
Injection 50 mg in 2 mL vial Injection 5 .. MX, PU
Solution concentrate for I.V. infusion 500 mg in 5 mL vial Injection 1 .. IT
Solution concentrate for I.V. infusion 500 mg in 20 mL vial Injection 1 .. MX
Solution concentrate for I.V. infusion 1000 mg in 10 mL vial Injection 1 .. IT, MX
Solution concentrate for I.V. infusion 5000 mg in 50 mL vial Injection 1 .. IT
Methyldopa Tablet 250 mg Oral 100 5 AF, MK
Methylphenidate Hydrochloride Tablet 10 mg Oral 100 5 AF, NV
Tablet 18 mg (extended release) Oral 30 5 JC
Tablet 36 mg (extended release) Oral 30 5 JC
Tablet 54 mg (extended release) Oral 30 5 JC
Methylprednisolone Aceponate Cream 1 mg per g, 15 g Application 1 .. CS
Ointment 1 mg per g, 15 g Application 1 .. CS
Fatty ointment 1 mg per g, 15 g Application 1 .. CS
Lotion 1 mg per g, 20 g Application 1 .. CS
Methylprednisolone Acetate Injection 40 mg in 1 mL vial Injection 5 .. KR, PH
Methylprednisolone Sodium Succinate Powder for injection equivalent to 40 mg methylprednisolone with diluent Injection 5 .. PF
Powder for injection equivalent to 1 g methylprednisolone with diluent Injection 1 .. PF
Methysergide Maleate Tablet equivalent to 1 mg methysergide Oral 100 2 NV
Metoclopramide Hydrochloride Tablet 10 mg Oral 25 .. AF, VT
Oral solution 5 mg per 5 mL, 100 mL Oral 1 .. VT
Injection 10 mg in 2 mL ampoule Injection 10 .. VT
Metoprolol Succinate Pack containing 15 tablets 23.75 mg (controlled release), 15 tablets 47.5 mg (controlled release) and 15 tablets 95 mg (controlled release) Oral 1 .. AP
Tablet 23.75 mg (controlled release) Oral 15 .. AP
Tablet 47.5 mg (controlled release) Oral 30 5 AP
Tablet 95 mg (controlled release) Oral 30 5 AP
Tablet 190 mg (controlled release) Oral 30 5 AP
Metoprolol Tartrate Tablet 50 mg Oral 100 5 AF, AP, AW, CH, GM, GX, HX, NV, TW
Tablet 100 mg Oral 60 5 AF, AP, AW, CH, GM, GX, HX, NV, TW
Metronidazole Tablet 200 mg Oral 21 1 AF, AV, HP
Tablet 400 mg Oral 5 2 AF
I.V. infusion 500 mg in 100 mL Injection 5 1 BX
Suppositories 500 mg, 10 Rectal 1 .. AV
Metronidazole Benzoate Oral suspension 320 mg per 5 mL, 100 mL Oral 1 .. AV
Mexiletine Hydrochloride Capsule 50 mg Oral 100 5 BY
Capsule 200 mg Oral 100 5 BY
Mianserin Hydrochloride Tablet 10 mg Oral 50 5 AF, OR
Tablet 20 mg Oral 50 5 AF, OR
Miconazole Tincture 20 mg per mL, 30 mL Application 1 2 JC
Miconazole Nitrate Cream 20 mg per g, 15 g Application 2 3 JC
Cream 20 mg per g, 30 g Application 1 2 JC
Cream 20 mg per g, 70 g Application 1 1 JC
Powder 20 mg per g, 30 g Application 1 2 JC
Lotion 20 mg per mL, 30 g Application 1 2 JC
"Minaphlex" Sachets containing oral powder 29 g, 30 Oral 4 5 SB
Minocycline Hydrochloride Tablet equivalent to 50 mg minocycline Oral 60 5 AF, SI
Capsule equivalent to 100 mg minocycline Oral 11 .. AF
Minoxidil Tablet 10 mg Oral 100 5 PH
Mirtazapine Tablet 15 mg (orally disintegrating) Oral 30 5 BP
Tablet 30 mg Oral 30 5 AF, AW, BP, GM, OR, SZ
Tablet 30 mg (orally disintegrating) Oral 30 5 BP
Tablet 45 mg Oral 30 5 AW, BP, SZ
Tablet 45 mg (orally disintegrating) Oral 30 5 BP
Misoprostol Tablet 200 micrograms Oral 120 2 PH
Mitozantrone Hydrochloride Injection equivalent to 10 mg mitozantrone in 5 mL Injection 1 .. PU
Injection equivalent to 20 mg mitozantrone in 10 mL Injection 1 .. BX, MX, PU
Injection equivalent to 25 mg mitozantrone in 12.5 mL Injection 1 .. BX, PU
Moclobemide Tablet 150 mg Oral 60 5 AF, AL, CH, GM, GX, HX, RO, TW
Tablet 300 mg Oral 60 5 AF, AL, CH, GM, GX, HX, RO, SI, TW
Modafinil Tablet 100 mg Oral 120 5 CS
Mometasone Furoate Cream 1 mg per g, 15 g Application 1 .. EX, SH
Ointment 1 mg per g, 15 g Application 1 .. EX, SH
Lotion 1 mg per g, 30 mL Application 1 .. EX, SH
"Monogen" Oral powder 400 g Oral 8 5 SB
Montelukast Sodium Tablet, chewable, equivalent to 4 mg montelukast Oral 28 5 MK
Tablet, chewable, equivalent to 5 mg montelukast Oral 28 5 MK
Morphine Hydrochloride Oral solution 2 mg per mL, 200 mL Oral 1 .. MF
Oral solution 5 mg per mL, 200 mL Oral 1 .. MF
Oral solution 10 mg per mL, 200 mL Oral 1 .. MF
Morphine Sulfate Tablet 10 mg Oral 20 .. MF
Tablet 20 mg Oral 20 .. MF
Tablet 30 mg Oral 20 .. FM
Tablet 5 mg (controlled release) Oral 20 .. MF
Tablet 10 mg (controlled release) Oral 20 .. MF
Tablet 15 mg (controlled release) Oral 20 .. MF
Tablet 30 mg (controlled release) Oral 20 .. MF
Tablet 60 mg (controlled release) Oral 20 .. MF
Tablet 100 mg (controlled release) Oral 20 .. MF
Tablet 200 mg (controlled release) Oral 20 .. MF
Capsule 10 mg (containing sustained release pellets) Oral 20 .. GK
Capsule 20 mg (containing sustained release pellets) Oral 20 .. GK
Capsule 30 mg (controlled release) Oral 10 .. MF
Capsule 50 mg (containing sustained release pellets) Oral 20 .. GK
Capsule 60 mg (controlled release) Oral 10 .. MF
Capsule 90 mg (controlled release) Oral 10 .. MF
Capsule 100 mg (containing sustained release pellets) Oral 20 .. GK
Capsule 120 mg (controlled release) Oral 10 .. MF
Sachet containing controlled release granules for oral suspension, 20 mg per sachet Oral 20 .. MF
Sachet containing controlled release granules for oral suspension, 30 mg per sachet Oral 20 .. MF
Sachet containing controlled release granules for oral suspension, 60 mg per sachet Oral 20 .. MF
Sachet containing controlled release granules for oral suspension, 100 mg per sachet Oral 20 .. MF
Sachet containing controlled release granules for oral suspension, 200 mg per sachet Oral 20 .. MF
Injection 10 mg in 1 mL ampoule Injection 5 .. MX
Injection 15 mg in 1 mL ampoule Injection 5 .. MX
Injection 30 mg in 1 mL ampoule Injection 5 .. MX
Morphine Tartrate Injection 120 mg in 1.5 mL ampoule Injection 5 .. MX
Moxonidine Tablet 200 micrograms Oral 30 5 SM
Tablet 400 micrograms Oral 30 5 SM
"MSUD AID III" Oral powder 500 g Oral 4 5 SB
"MSUD Analog" Oral powder 400 g Oral 8 5 SB
"MSUD Express" Sachets containing oral powder 25 g, 30 Oral 4 5 VF
"MSUD-gel" Sachets containing oral powder 20 g, 30 Oral 4 5 VF
"MSUD Maxamaid" Oral powder 500 g Oral 8 5 SB
"MSUD Maxamum" Oral powder 500 g Oral 8 5 SB
Mycophenolate Mofetil Capsule 250 mg Oral 300 3 RO
Tablet 500 mg Oral 150 3 RO
Mycophenolate Mofetil with Water - Purified BP Powder for oral suspension 1 g per 5 mL, 165 mL Oral 1 3 RO
Mycophenolate Sodium Tablet (enteric coated) equivalent to 180 mg mycophenolic acid Oral 120 3 NV
Tablet (enteric coated) equivalent to 360 mg mycophenolic acid Oral 120 3 NV
Nafarelin Acetate Nasal spray (pump pack) equivalent to 200 micrograms nafarelin per dose, 60 doses Nasal 1 5 PH
Naloxone Hydrochloride Injection 800 micrograms in 2 mL disposable injection set Injection 1 .. CS
Injection 2 mg in 5 mL disposable injection set Injection 1 .. CS
Naltrexone Hydrochloride Tablet 50 mg Oral 30 1 BQ
Nandrolone Decanoate Injection 50 mg in 1 mL disposable syringe Injection 1 7 OR
Naproxen Tablet 250 mg Oral 100 3 AF, RO
Tablet 500 mg Oral 50 3 AF, RO
Tablet 750 mg (sustained release) Oral 28 3 MD, RO
Tablet 1 g (sustained release) Oral 28 3 MD, RO
Oral suspension 125 mg per 5 mL, 474 mL Oral 1 3 RO
Naproxen Sodium Tablet 550 mg Oral 50 3 MD, RO
Naratriptan Hydrochloride Tablet equivalent to 2.5 mg naratriptan Oral 4 5 GK
Nedocromil Sodium Pressurised inhalation 2 mg per dose, 112 doses (CFC-free formulation) Inhalation by mouth 1 5 AV
"Neocate" Oral powder 400 g Oral 8 5 SB
"Neocate Advance" Oral powder 400 g Oral 8 5 SB
Neomycin Sulfate Tablet 500 mg Oral 25 1 AF
Neomycin Undecenoate with Bacitracin Zinc Ear ointment 12 mg (3.5 mg neomycin)-400 units per g, 10 g Application to the ear 1 ..
Nicorandil Tablets 10 mg, 60 Oral 1 5 AV
Tablets 20 mg, 60 Oral 1 5 AV
Nifedipine Tablet 10 mg Oral 60 5 AF, AW, BN
Tablet 20 mg Oral 60 5 AF, AW, BN, CH, GM, GX, HX, TW
Tablet 20 mg (controlled release) Oral 30 5 BN
Tablet 30 mg (controlled release) Oral 30 5 AF, AW, BN
Tablet 60 mg (controlled release) Oral 30 5 AF, AW, BN
Nilutamide Tablet 150 mg Oral 30 5 AV
Nitrazepam Tablet 5 mg Oral 25 .. AF, VT
Nitrofurantoin Capsule 50 mg Oral 30 1 PU
Capsule 100 mg Oral 30 1 PU
Nizatidine Capsule 150 mg Oral 60 5 AF, AS, LN
Capsule 300 mg Oral 30 5 AF, AS, LN
Norethisterone Tablets 350 micrograms, 28 Oral 4 2 JC, KR, PH
Tablet 5 mg Oral 30 2 SC
Norethisterone with Ethinyloestradiol Tablets 500 micrograms-35 micrograms, 21 Oral 4 2 PH
Pack containing 21 tablets 500 micrograms-35 micrograms and 7 inert tablets Oral 4 2 KR, PH
Tablets 1 mg-35 micrograms, 21 Oral 4 2 PH
Pack containing 21 tablets 1 mg-35 micrograms and 7 inert tablets Oral 4 2 KR, PH
Pack containing 12 tablets 500 micrograms-35 micrograms, 9 tablets 1 mg-35 micrograms and 7 inert tablets Oral 4 2 KR, PH
Norethisterone with Mestranol Tablets 1 mg-50 micrograms, 21 Oral 4 2 PH
Pack containing 21 tablets 1 mg-50 micrograms and 7 inert tablets Oral 4 2 PH
Norfloxacin Tablet 400 mg Oral 14 1 AF, AW, CH, GM, GX, HX, MK, TW
Nortriptyline Hydrochloride Tablet equivalent to 10 mg nortriptyline Oral 50 2 AS
Tablet equivalent to 25 mg nortriptyline Oral 50 2 AS
Nystatin Tablet 500,000 units Oral 50 .. SI
Capsule 500,000 units Oral 50 .. SI
Oral suspension 100,000 units per mL, 24 mL Oral 1 1 BQ, SI
Cream 100,000 units per g, 15 g Application 2 3 BQ
Oestradiol Tablet 2 mg Oral 56 2 SM
Transdermal patches 390 micrograms, 8 Transdermal 1 5 NV
Transdermal patches 2 mg, 4 Transdermal 1 5 MM, SC
Transdermal patches 2 mg, 8 Transdermal 1 5 NV
Transdermal patches 585 micrograms, 8 Transdermal 1 5 NV
Transdermal patches 3.28 mg, 8 Transdermal 1 5 NV
Transdermal patches 3.8 mg, 4 Transdermal 1 5 MM, SC
Transdermal patches 4 mg, 8 Transdermal 1 5 NV
Transdermal patches 780 micrograms, 8 Transdermal 1 5 NV
Transdermal patches 4.33 mg, 8 Transdermal 1 5 NV
Transdermal patches 5.7 mg, 4 Transdermal 1 5 SC
Transdermal patches 1.17 mg, 8 Transdermal 1 5 NV
Transdermal patches 6.57 mg, 8 Transdermal 1 5 NV
Transdermal patches 7.6 mg, 4 Transdermal 1 5 MM, SC
Transdermal patches 8 mg, 8 Transdermal 1 5 NV
Transdermal patches 1.56 mg, 8 Transdermal 1 5 NV
Transdermal patches 8.66 mg, 8 Transdermal 1 5 NV
Vaginal tablets 25 micrograms, 15 Vaginal 1 2 NO
Oestradiol and Oestradiol with Dydrogesterone Pack containing 14 tablets oestradiol 2 mg and 14 tablets oestradiol 2 mg with dydrogesterone 10 mg Oral 1 5 SM
Oestradiol and Oestradiol with Norethisterone Acetate Pack containing 12 tablets oestradiol 2 mg, 10 tablets oestradiol 2 mg with norethisterone acetate 1 mg and 6 tablets oestradiol 1 mg Oral 1 5 NO
Pack containing 4 transdermal patches oestradiol 4 mg and 4 transdermal patches oestradiol 10 mg with norethisterone acetate 30 mg Transdermal 1 5 NV
Oestradiol Hemihydrate Nasal spray 150 micrograms per actuation, 60 actuations, 4.2 mL Nasal 1 5 SE
Transdermal gel equivalent to 1 mg oestradiol in 1 g sachet, 28 Transdermal 1 5 OR
Transdermal patches equivalent to 750 micrograms oestradiol, 8 Transdermal 1 5 NV
Transdermal patches equivalent to 1.5 mg oestradiol, 8 Transdermal 1 5 NV
Transdermal patches equivalent to 3 mg oestradiol, 8 Transdermal 1 5 NV
Oestradiol Hemihydrate and Oestradiol Hemihydrate with Norethisterone Acetate Pack containing 4 transdermal patches equivalent to 4.33 mg oestradiol and 4 transdermal patches equivalent to 620 micrograms oestradiol with 2.7 mg norethisterone acetate Transdermal 1 5 NV
Pack containing 4 transdermal patches equivalent to 4.33 mg oestradiol and 4 transdermal patches equivalent to 510 micrograms oestradiol with 4.8 mg norethisterone acetate Transdermal 1 5 NV
Oestradiol Hemihydrate with Norethisterone Acetate Tablets equivalent to 1 mg oestradiol with 500 micrograms norethisterone acetate, 28 Oral 1 5 NO
Tablets equivalent to 2 mg oestradiol with 1 mg norethisterone acetate, 28 Oral 1 5 NO
Transdermal patches equivalent to 620 micrograms oestradiol with 2.7 mg norethisterone acetate, 8 Transdermal 1 5 NV
Transdermal patches equivalent to 510 micrograms oestradiol with 4.8 mg norethisterone acetate, 8 Transdermal 1 5 NV
Oestradiol Valerate Tablet 1 mg Oral 56 2 SC
Tablet 2 mg Oral 56 2 SC
Oestriol Pessaries 500 micrograms, 15 Vaginal 1 2 OR
Vaginal cream 1 mg per g, 15 g Application 1 1 OR
Oestrogens—Conjugated Tablet 300 micrograms Oral 56 2 WY
Tablet 625 micrograms Oral 56 2 WY
Oestrogens—Conjugated with Medroxyprogesterone Acetate Tablets 625 micrograms-2.5 mg, 28 Oral 1 5 WY
Tablets 625 micrograms-5 mg, 28 Oral 1 5 WY
Ofloxacin Eye drops 3 mg per mL, 5 mL Application to the eye 2 .. AG
Olanzapine Tablet 2.5 mg Oral 28 5 LY
Tablet 5 mg Oral 28 5 LY
Tablet 7.5 mg Oral 28 5 LY
Tablet 10 mg Oral 28 5 LY
Wafer 5 mg Oral 28 5 LY
Wafer 10 mg Oral 28 5 LY
Olsalazine Sodium Capsule 250 mg Oral 100 5 UC
Tablet 500 mg Oral 100 5 UC
Omeprazole Tablet 20 mg Oral 30 1 HX, SL
Capsule 20 mg Oral 30 1 SZ
Omeprazole and Clarithromycin and Amoxycillin Trihydrate Pack containing 14 capsules omeprazole 20 mg, 14 tablets clarithromycin 500 mg and 28 capsules amoxycillin trihydrate equivalent to 500 mg amoxycillin Oral 1 .. AB
Omeprazole Magnesium Tablet equivalent to 20 mg omeprazole Oral 30 1 AL, AP, PM
Tablet equivalent to 10 mg omeprazole Oral 30 5 AP
Ondansetron Wafer 4 mg Oral 4 .. GK, HX, RE
Wafer 8 mg Oral 4 .. GK, HX, RE
Ondansetron Hydrochloride Dihydrate Tablet equivalent to 4 mg ondansetron Oral 4 .. AW, GK, HX, RE
Tablet equivalent to 8 mg ondansetron Oral 4 .. AW, GK, HX, RE
Syrup equivalent to 4 mg ondansetron per 5 mL, 50 mL Oral 1 1 GK
I.V. injection equivalent to 4 mg ondansetron in 2 mL ampoule Injection 1 .. GK, HX, RE
I.V. injection equivalent to 8 mg ondansetron in 4 mL ampoule Injection 1 .. GK, HX, RE
Oxaliplatin Solution concentrate for I.V. infusion 50 mg in 10 mL Injection 1 2 SW
Powder for I.V. infusion 50 mg Injection 1 2 IT, MX, SW, ZP
Solution concentrate for I.V. infusion 100 mg in 20 mL Injection 1 2 SW
Powder for I.V. infusion 100 mg Injection 1 2 IT, MX, SW, ZP
Oxazepam Tablet 15 mg Oral 25 .. AF, SI
Tablet 30 mg Oral 25 .. AF, FM, SI
Oxcarbazepine Tablet 150 mg Oral 100 5 NV
Tablet 300 mg Oral 100 5 NV
Tablet 600 mg Oral 100 5 NV
Oral suspension 60 mg per mL, 250 mL Oral 2 5 NV
Oxprenolol Hydrochloride Tablet 20 mg Oral 100 5 AF
Tablet 40 mg Oral 100 5 AF
Oxybutynin Hydrochloride Tablet 5 mg Oral 100 5 AV
Oxycodone Hydrochloride Tablet 5 mg Oral 20 .. SI
Capsule 5 mg Oral 20 .. MF
Capsule 10 mg Oral 20 .. MF
Capsule 20 mg Oral 20 .. MF
Oral solution 5 mg per 5 mL, 250 mL Oral 1 .. MF
Tablet 5 mg (controlled release) Oral 20 .. MF
Tablet 10 mg (controlled release) Oral 20 .. MF
Tablet 20 mg (controlled release) Oral 20 .. MF
Tablet 40 mg (controlled release) Oral 20 .. MF
Tablet 80 mg (controlled release) Oral 20 .. MF
Oxycodone Pectinate Suppository equivalent to 30 mg oxycodone Rectal 12 .. PL
Paclitaxel Solution concentrate for I.V. infusion 30 mg in 5 mL vial Injection 5 .. BQ, IT, MX
Solution concentrate for I.V. infusion 100 mg in 16.7 mL vial Injection 2 .. BQ, IT, MX
Solution concentrate for I.V. infusion 150 mg in 25 mL vial Injection 2 .. BQ, IT, MX
Solution concentrate for I.V. infusion 300 mg in 50 mL vial Injection 1 .. BQ, IT, MX
Pancreatic Extract Capsule (containing enteric coated minimicrospheres) providing not less than 5,000 BP units of lipase activity Oral 500 10 SM
Capsule (containing enteric coated minimicrospheres) providing not less than 10,000 BP units of lipase activity Oral 500 10 SM
Capsule (containing enteric coated minimicrospheres) providing not less than 25,000 BP units of lipase activity Oral 200 10 SM
Pancrelipase Capsule (containing enteric coated microspheres) providing not less than 10,000 BP units of lipase activity Oral 500 10 OR
Capsule (containing enteric coated microtablets) providing not less than 25,000 BP units of lipase activity Oral 200 10 TM
Pantoprazole Sodium Sesquihydrate Tablet (enteric coated), equivalent to 40 mg pantoprazole Oral 30 2 AH
Tablet (enteric coated), equivalent to 20 mg pantoprazole Oral 30 5 AH
Paracetamol Tablet 500 mg Oral 100 1 AW, CH, FM, GM, HX, JT, PC, SW, TW
Tablet 665 mg (modified release) Oral 192 5 GC, ME
Oral liquid 120 mg per 5 mL, 100 mL Oral 1 2 SW
Oral liquid 240 mg per 5 mL, 200 mL Oral 1 2 SW
Paraffin - Soft White with Paraffin - Liquid Eye ointment, compound, 3.5 g Application to the eye 2 5 AQ, IQ
Pack containing 2 tubes eye ointment, compound, 3.5 g Application to the eye 1 5 AG, IQ, PE
Paroxetine Hydrochloride Tablet equivalent to 20 mg paroxetine Oral 30 5 AF, AW, CH, GK, GM, GX, SZ, TW
Pemetrexed Disodium Heptahydrate Powder for I.V. infusion equivalent to 500 mg pemetrexed, vial Injection 2 2 LY
Penicillamine Tablet 125 mg Oral 100 1 AL
Tablet 250 mg Oral 100 1 AL
"Pepti-Junior" Oral powder 450 g Oral 8 5 NU
Pergolide Mesylate Tablet equivalent to 50 micrograms pergolide Oral 100 .. AS
Tablet equivalent to 250 micrograms pergolide Oral 100 5 AS
Tablet equivalent to 1 mg pergolide Oral 100 5 AS
Perhexiline Maleate Tablet 100 mg Oral 100 5 SI
Pericyazine Tablet 2.5 mg Oral 100 5 AV
Tablet 10 mg Oral 100 5 AV
Perindopril Arginine Tablet 2.5 mg Oral 30 5 SE
Tablet 5 mg Oral 30 5 SE
Tablet 10 mg Oral 30 5 SE
Perindopril Erbumine Tablet 2 mg Oral 30 5 AF, CH, GX, TW
Tablet 4 mg Oral 30 5 AF, CH, GX, TW
Tablet 8 mg Oral 30 5 AF, CH, GX, TW
Perindopril Erbumine with Indapamide Hemihydrate Tablet 4 mg-1.25 mg Oral 30 5 SE
Permethrin Cream 50 mg per g, 30 g Application 1 1 PC
Phenelzine Sulfate Tablet equivalent to 15 mg phenelzine Oral 100 1 LM
"Phenex-1" Oral powder 350 g Oral 8 5 AB
"Phenex-2" Oral powder 325 g Oral 10 5 AB
Oral powder 400 g Oral 8 5 AB
Phenobarbitone Tablet 30 mg Oral 200 4 SI
Phenobarbitone Sodium Injection 200 mg in 1 mL ampoule Injection 5 .. FM
Phenoxybenzamine Hydrochloride Capsule 10 mg Oral 100 5 GH
Phenoxymethylpenicillin Benzathine Oral suspension equivalent to 125 mg phenoxymethylpenicillin per 5 mL, 100 mL Oral 2 .. FM, SI
Oral suspension equivalent to 250 mg phenoxymethylpenicillin per 5 mL, 100 mL Oral 2 .. FM, SI
Phenoxymethylpenicillin Potassium Tablet equivalent to 250 mg phenoxymethylpenicillin Oral 50 .. SI
Tablet equivalent to 500 mg phenoxymethylpenicillin Oral 50 .. SI
Capsule equivalent to 250 mg phenoxymethylpenicillin Oral 50 .. CS, FM, GM, HX
Capsule equivalent to 500 mg phenoxymethylpenicillin Oral 50 .. CS, FM, GM, HX
Phenytoin Tablet 50 mg Oral 200 2 PF
Oral suspension 30 mg per 5 mL, 500 mL Oral 1 3 PF
Phenytoin Sodium Capsule 30 mg Oral 200 2 PF
Capsule 100 mg Oral 200 2 PF
"Phlexy-10" Capsules 500 mg, 200 Oral 16 5 SB
Tablets 1 g, 75 Oral 24 5 SB
Bars 42 g, 20 Oral 10 5 SB
"Phlexy-10 Drink Mix" Sachets containing oral powder 20 g, 30 Oral 7 5 SB
Pilocarpine Hydrochloride Eye drops 5 mg per mL, 15 mL Application to the eye 1 5 AG, PE
Eye drops 10 mg per mL, 15 mL Application to the eye 1 5 AG, AQ, PE
Eye drops 20 mg per mL, 15 mL Application to the eye 1 5 AG, AQ, PE
Eye drops 40 mg per mL, 15 mL Application to the eye 1 5 AG, AQ, PE
Eye drops 60 mg per mL, 15 mL Application to the eye 1 5 AG, PE
Pimecrolimus Cream 10 mg per g, 15 g Application 1 1 NV
Pindolol Tablet 5 mg Oral 100 5 AF, NV
Tablet 15 mg Oral 50 5 AF, NV
Pioglitazone Hydrochloride Tablet equivalent to 15 mg pioglitazone Oral 28 5 LY
Tablet equivalent to 30 mg pioglitazone Oral 28 5 LY
Tablet equivalent to 45 mg pioglitazone Oral 28 5 LY
Piperazine Oestrone Sulfate Tablet 730 micrograms Oral 56 2 KR, PH
Tablet 1.46 mg Oral 56 2 KR, PH
Piroxicam Dispersible tablet 10 mg Oral 50 3 AF, GX, HX, PF
Dispersible tablet 20 mg Oral 25 3 AF, CH, GX, HX, PF, TW
Capsule 10 mg Oral 50 3 AF, CH, GX, PF, TW
Capsule 20 mg Oral 25 3 AF, CH, GX, PF, TW
Pizotifen Malate Tablet equivalent to 500 micrograms pizotifen Oral 100 2 NV
"PK AID II" Oral powder 250 g Oral 8 5 SB
"PKU-Express" Sachets containing oral powder 25 g, 30 Oral 4 5 VF
"PKU Express Liquid" Oral liquid 130 mL, 30 Oral 4 5 VF
"PKU-gel" Sachets containing oral powder 20 g, 30 Oral 4 5 VF
Pneumococcal Vaccine - Polyvalent Injection 0.5 mL vial (23 valent) Injection 1 .. CS
Polyethylene Glycol 400 with Propylene Glycol Eye drops 4 mg-3 mg per mL, 15 mL Application to the eye 1 5 AQ
Polygeline I.V. infusion 17.5 g per 500 mL with electrolytes, 500 mL Injection 3 .. AE
Polyvinyl Alcohol Eye drops 14 mg per mL, 15 mL Application to the eye 1 5 AG, PE
Eye drops 14 mg per mL, 15 mL (contains sodium chlorite/hydrogen peroxide as preservative) Application to the eye 1 5 AE
Eye drops 30 mg per mL, 15 mL Application to the eye 1 5 AG, PE
Eye drops 30 mg per mL, 15 mL (contains sodium chlorite/hydrogen peroxide as preservative) Application to the eye 1 5 AE
Potassium Chloride Tablet 600 mg (sustained release) Oral 200 1 AS, NM, NV
Potassium Chloride with Potassium Bicarbonate Tablet, effervescent, 14 mmol K+ and 8 mmol Cl- Oral 60 1 AS, LN
Pravastatin Sodium Tablet 10 mg Oral 30 5 AF, AW, BQ, CH, GM, GX, RE, SZ, TW
Tablet 20 mg Oral 30 5 AF, AW, BQ, CH, GM, GX, RE, SZ, TW
Tablet 40 mg Oral 30 5 AF, AW, BQ, CH, GM, GX, RE, SZ, TW
Tablet 80 mg Oral 30 5 AW, BQ
Prazosin Hydrochloride Tablet equivalent to 1 mg prazosin Oral 100 5 AF, CH, GX, PF, TW
Tablet equivalent to 2 mg prazosin Oral 100 5 AF, CH, GX, PF, TW
Tablet equivalent to 5 mg prazosin Oral 100 5 AF, CH, GX, PF, TW
Prednisolone Tablet 1 mg Oral 100 4 AS, LN
Tablet 5 mg Oral 60 4 AS, FM
Tablet 25 mg Oral 30 4 AS, FM
Prednisolone Acetate with Phenylephrine Hydrochloride Eye drops 10 mg-1.2 mg per mL, 10 mL Application to the eye 1 2 AG
Prednisolone Sodium Phosphate Oral solution equivalent to 5 mg prednisolone per mL, 30 mL Oral 1 5 AS, LN
Enema, retention, equivalent to 20 mg prednisolone in 100 mL Rectal 28 3 SI
Suppositories equivalent to 5 mg prednisolone, 10 Rectal 3 3 SI
Prednisone Tablet 1 mg Oral 100 4 AS, LN
Tablet 5 mg Oral 60 4 AS, FM
Tablet 25 mg Oral 30 4 AS, FM
Primidone Tablet 250 mg Oral 200 2 LM
Probenecid Tablet 500 mg Oral 100 5 PL
Procaine Penicillin Injection 1.5 g in disposable syringe Injection 5 .. SI
Prochlorperazine Suppositories 3 mg, equivalent to 5 mg prochlorperazine maleate, 5 Rectal 1 2 AV
Suppositories 15 mg, equivalent to 25 mg prochlorperazine maleate, 5 Rectal 1 2 AV
Prochlorperazine Maleate Tablet 5 mg Oral 25 .. AV, HP
Prochlorperazine Mesylate Injection 12.5 mg in 1 mL ampoule Injection 10 .. AV
Promethazine Hydrochloride Injection 50 mg in 2 mL ampoule Injection 10 .. MX
Propantheline Bromide Tablet 15 mg Oral 200 5 SI
"Pro-Phree" Oral powder 400 g Oral 8 5 AB
Propranolol Hydrochloride Tablet 10 mg Oral 100 5 AF, AP
Tablet 40 mg Oral 100 5 AF, AP
Tablet 160 mg Oral 50 5 AF
Propylthiouracil Tablet 50 mg Oral 200 2 PL
Pyrantel Embonate Tablet equivalent to 125 mg pyrantel Oral 6 .. AF
Tablet equivalent to 250 mg pyrantel Oral 6 .. AF
Pyridostigmine Bromide Tablet 10 mg Oral 100 5 VT
Tablet 60 mg Oral 150 5 VT
Tablet 180 mg (modified release) Oral 100 5 VT
Pyrimethamine Tablet 25 mg Oral 50 .. GK
Quetiapine Fumarate Tablet equivalent to 25 mg quetiapine Oral 60 5 AP
Tablet equivalent to 100 mg quetiapine Oral 90 5 AP
Tablet equivalent to 200 mg quetiapine Oral 60 5 AP
Tablet equivalent to 300 mg quetiapine Oral 60 5 AP
Quinagolide Hydrochloride Pack containing 3 tablets equivalent to 25 micrograms quinagolide and 3 tablets equivalent to 50 micrograms quinagolide Oral 1 .. FP
Tablet equivalent to 75 micrograms quinagolide Oral 30 5 FP
Quinapril Hydrochloride Tablet equivalent to 5 mg quinapril Oral 30 5 AF, AW, PF
Tablet equivalent to 10 mg quinapril Oral 30 5 AF, AW, PF
Tablet equivalent to 20 mg quinapril Oral 30 5 AF, AW, PF
Quinapril Hydrochloride with Hydrochlorothiazide Tablet equivalent to 10 mg quinapril with 12.5 mg hydrochlorothiazide Oral 30 5 PF
Tablet equivalent to 20 mg quinapril with 12.5 mg hydrochlorothiazide Oral 30 5 PF
Quinine Bisulfate Tablet 300 mg Oral 50 2 AS
Quinine Sulfate Tablet 300 mg Oral 50 2 AS, LN
Rabeprazole Sodium Tablet 20 mg (enteric coated) Oral 30 2 JC
Tablet 10 mg (enteric coated) Oral 28 5 JC
Raloxifene Hydrochloride Tablet 60 mg Oral 28 5 LY
Raltitrexed Powder for I.V. infusion 2 mg in single use vial Injection 3 2 AP
Ramipril Tablet 1.25 mg Oral 30 5 AV, ML, QM, WA
Tablet 2.5 mg Oral 30 5 AV, ML, QM, WA
Tablet 5 mg Oral 30 5 AV, ML, QM, WA
Capsule 10 mg Oral 30 5 AV, ML, QM, WA
Pack containing 7 tablets 2.5 mg, 21 tablets 5 mg and 10 capsules 10 mg Oral 1 .. AV
Ranitidine Hydrochloride Tablet equivalent to 150 mg ranitidine Oral 60 5 AF, CH, GK, GM, GX, HX, RA, SI, TW
Tablet, effervescent, equivalent to 150 mg ranitidine Oral 60 5 GK
Tablet equivalent to 300 mg ranitidine Oral 30 5 AF, CH, GK, GM, GX, HX, RA, SI, TW
Syrup equivalent to 150 mg ranitidine per 10 mL, 300 mL Oral 2 5 GK
"RCF" Oral liquid 384 mL Oral 120 5 AB
Reboxetine Mesilate Tablet equivalent to 4 mg reboxetine Oral 60 5 PH
Reteplase Pack containing 2 vials powder for injection 10 units, 2 single use pre-filled syringes with solvent, 2 reconstitution spikes and 2 needles Injection 1 .. RO
Rifampicin Capsule 150 mg Oral 10 .. AF
Capsule 300 mg Oral 10 .. AF
Syrup 100 mg per 5 mL, 60 mL Oral 1 .. AV
Riluzole Tablet 50 mg Oral 56 5 AV
Risedronate Sodium Tablet 5 mg Oral 28 5 AV
Tablet 35 mg Oral 4 5 AV
Tablet 30 mg Oral 28 1 AV
Risedronate Sodium and Calcium Carbonate Pack containing 4 tablets risedronate sodium 35 mg and 24 tablets calcium carbonate 1.25 g (equivalent to 500 mg calcium) Oral 1 5 AV
Risperidone Tablet 0.5 mg Oral 60 2 JC
Tablet 0.5 mg (orally disintegrating) Oral 56 2 JC
Tablet 1 mg Oral 60 2 JC
Tablet 1 mg (orally disintegrating) Oral 56 2 JC
Tablet 2 mg Oral 60 2 JC
Tablet 2 mg (orally disintegrating) Oral 56 2 JC
Tablet 3 mg Oral 60 5 JC
Tablet 3 mg (orally disintegrating) Oral 56 5 JC
Tablet 4 mg Oral 60 5 JC
Tablet 4 mg (orally disintegrating) Oral 56 5 JC
Oral solution 1 mg per mL, 30 mL Oral 1 2 JC
Oral solution 1 mg per mL, 100 mL Oral 1 5 JC
I.M. injection (modified release), set containing 1 vial powder for injection 25 mg and 1 pre-filled syringe diluent 2 mL Injection 2 5 JC
I.M. injection (modified release), set containing 1 vial powder for injection 37.5 mg and 1 pre-filled syringe diluent 2 mL Injection 2 5 JC
I.M. injection (modified release), set containing 1 vial powder for injection 50 mg and 1 pre-filled syringe diluent 2 mL Injection 2 5 JC
Rituximab Solution for I.V. infusion 100 mg in 10 mL vial Injection 2 3 RO
Solution for I.V. infusion 500 mg in 50 mL vial Injection 1 3 RO
Rivastigmine Hydrogen Tartrate Capsule equivalent to 1.5 mg rivastigmine Oral 56 5 NV
Capsule equivalent to 3 mg rivastigmine Oral 56 5 NV
Capsule equivalent to 4.5 mg rivastigmine Oral 56 5 NV
Capsule equivalent to 6 mg rivastigmine Oral 56 5 NV
Oral solution equivalent to 2 mg rivastigmine per mL, 120 mL Oral 1 5 NV
Rosiglitazone Maleate Tablet equivalent to 4 mg rosiglitazone Oral 28 5 GK
Tablet equivalent to 8 mg rosiglitazone Oral 28 5 GK
Rosiglitazone Maleate with Metformin Hydrochloride Tablet equivalent to 2 mg rosiglitazone with 500 mg metformin hydrochloride Oral 56 5 GK
Tablet equivalent to 2 mg rosiglitazone with 1 g metformin hydrochloride Oral 56 5 GK
Tablet equivalent to 4 mg rosiglitazone with 500 mg metformin hydrochloride Oral 56 5 GK
Tablet equivalent to 4 mg rosiglitazone with 1 g metformin hydrochloride Oral 56 5 GK
Rosuvastatin Calcium Tablet equivalent to 5 mg rosuvastatin Oral 30 5 AP
Tablet equivalent to 10 mg rosuvastatin Oral 30 5 AP
Tablet equivalent to 20 mg rosuvastatin Oral 30 5 AP
Tablet equivalent to 40 mg rosuvastatin Oral 30 5 AP
Roxithromycin Tablet for oral suspension 50 mg Oral 10 1 AV
Tablet 150 mg Oral 10 1 AF, AV, AW, HP, HX
Tablet 300 mg Oral 5 1 AF, AV, AW, HP, HX
"S-26 LF" Infant formula powder 900 g Oral 5 .. WY
Salbutamol Sulfate Oral solution equivalent to 2 mg salbutamol per 5 mL, 150 mL Oral 2 5 GK
Capsule containing powder for oral inhalation equivalent to 200 micrograms salbutamol (for use in Ventolin Rotahaler) Inhalation by mouth 200 5 GK
Pressurised inhalation equivalent to 100 micrograms salbutamol per dose, 200 doses (CFC-free formulation) Inhalation by mouth 2 5 AL, AW, GK, MM
Pressurised inhalation in breath actuated device equivalent to 100 micrograms salbutamol per dose, 200 doses (CFC-free formulation) Inhalation by mouth 2 5 MM
Nebuliser solution equivalent to 2.5 mg salbutamol in 2.5 mL single dose units, 30 Inhalation 2 5 AF, AW, CH, GK, GX, PU, TW
Nebuliser solution equivalent to 5 mg salbutamol in 2.5 mL single dose units, 30 Inhalation 2 5 AF, AW, CH, GK, GX, TW
Nebuliser solution equivalent to 5 mg salbutamol per mL, 30 mL Inhalation 2 2 PU
Salcatonin Injection 50 I.U. in 1 mL ampoule Injection 30 5 NV
Injection 100 I.U. in 1 mL ampoule Injection 15 5 NV
Salmeterol Xinafoate Pressurised inhalation equivalent to 25 micrograms salmeterol per dose, 120 doses Inhalation by mouth 1 5 GK
Powder for oral inhalation in breath actuated device equivalent to 50 micrograms salmeterol per dose, 60 doses Inhalation by mouth 1 5 GK
Selegiline Hydrochloride Tablet 5 mg Oral 100 5 AF, GM
Sertraline Hydrochloride Tablet equivalent to 50 mg sertraline Oral 30 5 AF, AW, CH, GM, GX, PF, RA, SL, SZ, TW
Tablet equivalent to 100 mg sertraline Oral 30 5 AF, AW, CH, GM, GX, PF, RA, SL, SZ, TW
Silver Sulfadiazine with Chlorhexidine Gluconate Cream 10 mg-2 mg per g, 50 g Application 1 .. SN
Cream 10 mg-2 mg per g, 100 g Application 1 .. SN
Simvastatin Tablet 5 mg Oral 30 5 AF, BF, FR, HX, MK, RE
Tablet 10 mg Oral 30 5 AF, AW, BF, CH, FR, GM, GN, GX, HX, MK, RA, RE, TW
Tablet 20 mg Oral 30 5 AF, AW, BF, CH, FR, GM, GN, GX, HX, MK, RA, RE, TW
Tablet 40 mg Oral 30 5 AF, AW, BF, CH, FR, GM, GN, GX, HX, MK, RA, RE, TW
Tablet 80 mg Oral 30 5 AF, AW, BF, CH, FR, GM, GN, GX, HX, MK, RA, RE, TW
Sirolimus Tablet 1 mg Oral 100 3 WY
Tablet 2 mg Oral 100 3 WY
Oral solution 1 mg per mL, 60 mL Oral 1 3 WY
Sodium Acid Phosphate Tablet, compound effervescent, equivalent to 500 mg phosphorus Oral 100 5 NV
Sodium Alginate with Calcium Carbonate and Sodium Bicarbonate Oral liquid 1 g-320 mg-534 mg in 20 mL, 500 mL Oral 2 5 RC
Sodium Aurothiomalate Injection 10 mg ampoule Injection 10 .. AV
Injection 20 mg ampoule Injection 10 1 AV
Injection 50 mg ampoule Injection 10 1 AV
Sodium Chloride Injection 9 mg per mL, 10 mL Injection 5 1 PF
I.V. infusion 154 mmol per L, 1 L Injection 5 1 BX
I.V. infusion 513 mmol per L, 1 L Injection 2 1 BX
Sodium Chloride with Glucose I.V. infusion 31 mmol-222 mmol (anhydrous) per L, 1 L Injection 5 1 BX
I.V. infusion 19 mmol-104 mmol (anhydrous) per 500 mL, 500 mL Injection 5 1 BX
I.V. infusion 39 mmol-69 mmol (anhydrous) per 500 mL, 500 mL Injection 5 1 BX
Sodium Chloride with Potassium Chloride and Calcium Chloride I.V. infusion containing approximately 148 mmol Na+, 4 mmol K+, 2 mmol Ca2+ and 156 mmol Cl- per L, 1 L Injection 4 1 BX
Sodium Chloride with Sodium Acetate, Sodium Gluconate, Potassium Chloride and Magnesium Chloride Electrolyte replacement solution 5.26 g-3.68 g-5.02 g- 370 mg-300 mg per L, 1 L Injection 2 1 BX
Sodium Clodronate Tetrahydrate Capsule equivalent to 400 mg sodium clodronate Oral 100 2 SC
Tablet equivalent to 800 mg sodium clodronate Oral 60 2 SC
Sodium Cromoglycate Capsule containing powder for oral inhalation 20 mg (for use in Intal Spinhaler or Intal Halermatic) Inhalation by mouth 100 5 GM
Solution for inhalation 20 mg in 2 mL ampoule Inhalation 120 3 AV
Pressurised inhalation 1 mg per dose, 200 doses Inhalation by mouth 1 5 AV
Pressurised inhalation 1 mg per dose, 200 doses (CFC-free formulation) Inhalation by mouth 1 5 AV
Pressurised inhalation 5 mg per dose, 112 doses (CFC-free formulation) Inhalation by mouth 1 5 AV
Eye drops 20 mg per mL, 10 mL Application to the eye 1 5 AE, AV
Sodium Fusidate Tablet 250 mg Oral 36 1 CS
Sodium Lactate with Sodium Chloride, Potassium Chloride and Calcium Chloride I.V. infusion containing approximately 131 mmol Na+, 5 mmol K+, 2 mmol Ca2+, 29 mmol HCO3- (as lactate) and 111 mmol Cl- per L, 1 L Injection 5 1 BX
Sodium Valproate Tablet, crushable, 100 mg Oral 200 2 SW
Tablet 200 mg (enteric coated) Oral 200 2 AF, SW
Tablet 500 mg (enteric coated) Oral 200 2 AF, SW
Oral liquid 200 mg per 5 mL, 300 mL Oral 2 2 SW
Oral solution 200 mg per 5 mL, 300 mL Oral 2 2 SW
Sorbitol with Sodium Citrate and Sodium Lauryl Sulfoacetate Enemas 3.125 g-450 mg-45 mg in 5 mL, 12 Rectal 2 2 PH
Sotalol Hydrochloride Tablet 80 mg Oral 60 5 AW, BQ, GX, HX
Tablet 160 mg Oral 60 5 AF, AW, BQ, CH, GM, GX, HX, TW
Spironolactone Tablet 25 mg Oral 100 5 AF, PH
Tablet 100 mg Oral 100 5 AF, PH
Sterculia with Frangula Bark Granules 620 mg-80 mg per g, 500 g Oral 1 1 NE
Strontium Ranelate Sachet containing granules for oral suspension 2 g Oral 28 5 SE
Sucralfate Tablet equivalent to 1 g anhydrous sucralfate Oral 120 2 AF, AS
Sulfacetamide Sodium Eye drops 100 mg per mL, 15 mL Application to the eye 1 2 AG
Sulfasalazine Tablet 500 mg Oral 200 5 PH
Tablet 500 mg (enteric coated) Oral 200 5 KR, PH
Sulindac Tablet 100 mg Oral 100 3 AF
Tablet 200 mg Oral 50 3 AF
Sulthiame Tablet 50 mg Oral 200 2 PL
Tablet 200 mg Oral 200 2 PL
Sumatriptan Nasal spray 20 mg in 0.1 mL single dose unit Nasal 2 5 GK
Sumatriptan Succinate Tablet equivalent to 50 mg sumatriptan Oral 4 5 AF, GK, ME
Tablet (fast disintegrating) equivalent to 50 mg sumatriptan Oral 4 5 GK
Tacrolimus Capsule 500 micrograms Oral 100 3 JC
Capsule 1 mg Oral 100 3 JC
Capsule 5 mg Oral 50 3 JC
Tamoxifen Citrate Tablet equivalent to 10 mg tamoxifen Oral 60 5 AF, AP, GM
Tablet equivalent to 20 mg tamoxifen Oral 60 5 AF, AP, CH, GM, GX, HX, SI, TW
Telmisartan Tablet 40 mg Oral 28 5 BY
Tablet 80 mg Oral 28 5 BY
Telmisartan with Hydrochlorothiazide Tablet 40 mg-12.5 mg Oral 28 5 BY
Tablet 80 mg-12.5 mg Oral 28 5 BY
Temazepam Tablet 10 mg Oral 25 .. AF, FM, SI
Temozolomide Capsule 5 mg Oral 15 2 SH
Capsule 20 mg Oral 15 2 SH
Capsule 100 mg Oral 15 2 SH
Capsule 250 mg Oral 5 5 SH
Tenecteplase Powder for injection 40 mg vial with solvent Injection 1 .. BY
Powder for injection 50 mg vial with solvent Injection 1 .. BY
Terbinafine Hydrochloride Tablet equivalent to 250 mg terbinafine Oral 42 1 AF, AW, GM, GX, NV, SZ
Terbutaline Sulfate Injection 500 micrograms in 1 mL ampoule Injection 5 .. AP
Powder for oral inhalation in breath actuated device 500 micrograms per dose, 200 doses Inhalation by mouth 1 5 AP
Nebuliser solution 5 mg in 2 mL single dose units, 30 Inhalation 2 5 AP
Testosterone Subcutaneous implant 100 mg Subcutaneous implantation 6 .. OR
Subcutaneous implant 200 mg Subcutaneous implantation 3 .. OR
Transdermal gel 50 mg in 5 g sachet, 30 Transdermal 1 5 SC
Transdermal patches 12.2 mg, 60 Transdermal 1 5 MX
Transdermal patches 24.3 mg, 30 Transdermal 1 5 MX
Testosterone Enanthate Injection 250 mg in 1 mL Injection 3 3 SC
Testosterone Propionate with Testosterone Phenylpropionate, Testosterone Isocaproate and Testosterone Decanoate Injection 30 mg-60 mg-60 mg-100 mg in 1 mL ampoule Injection 3 3 OR
Testosterone Propionate with Testosterone Phenylpropionate and Testosterone Isocaproate Injection 20 mg-40 mg-40 mg in 1 mL ampoule Injection 3 3 OR
Testosterone Undecanoate Capsule 40 mg Oral 60 5 OR
I.M. injection 1,000 mg in 4 mL Injection 1 1 SC
Tetrabenazine Tablet 25 mg Oral 112 5 OA
Tetracosactrin Compound depot injection 1 mg in 1 mL ampoule Injection 5 5 NV
Theophylline Tablet 200 mg (sustained release) Oral 100 5 MM
Tablet 250 mg (sustained release) Oral 100 5 MM
Tablet 300 mg (sustained release) Oral 100 5 MM
Oral solution 133.3 mg per 25 mL, 500 mL Oral 1 5 MM
Thiamine Hydrochloride Tablet 100 mg Oral 100 2 AV
Thioguanine Tablet 40 mg Oral 25 1 GK
Thioridazine Hydrochloride Tablet 10 mg Oral 100 5 AF
Tablet 25 mg Oral 100 5 AF
Tablet 50 mg Oral 100 5 AF
Tablet 100 mg Oral 100 5 AF
Thiotepa Powder for injection 15 mg Injection or intravesical administra-tion 2 1 SI
Thyroxine Sodium Tablet equivalent to 50 micrograms anhydrous thyroxine sodium Oral 200 1 FM, SI
Tablet equivalent to 100 micrograms anhydrous thyroxine sodium Oral 200 1 FM, SI
Tablet equivalent to 200 micrograms anhydrous thyroxine sodium Oral 200 1 FM, SI
Tiagabine Hydrochloride Tablet equivalent to 5 mg tiagabine Oral 100 5 MX
Tablet equivalent to 10 mg tiagabine Oral 100 5 MX
Tablet equivalent to 15 mg tiagabine Oral 100 5 MX
Tiaprofenic Acid Tablet 300 mg Oral 60 3 AV
Ticarcillin Sodium with Potassium Clavulanate with any determined brand of Sodium Chloride Injection Powder for injection equivalent to 3 g ticarcillin-100 mg clavulanic acid (with required solvent) Injection 10 .. GK
Ticlopidine Hydrochloride Tablet 250 mg Oral 60 5 AF, HX, RO
Tiludronate Disodium Tablet equivalent to 200 mg tiludronic acid Oral 56 2 MX
Timolol Maleate Eye gel equivalent to 1 mg timolol per g, 5 g Application to the eye 1 5 NV
Eye drops equivalent to 2.5 mg timolol per mL, 5 mL Application to the eye 1 5 FR, SI
Eye drops equivalent to 5 mg timolol per mL, 5 mL Application to the eye 1 5 FR, SI
Eye drops (gellan gum solution) equivalent to 2.5 mg timolol per mL, 2.5 mL Application to the eye 1 5 MK
Eye drops (gellan gum solution) equivalent to 5 mg timolol per mL, 2.5 mL Application to the eye 1 5 MK
Tinidazole Tablet 500 mg Oral 4 .. GP, PF
Tiotropium Bromide Monohydrate Capsule containing powder for oral inhalation equivalent to 18 micrograms tiotropium (for use in HandiHaler) Inhalation by mouth 30 5 BY
Tirofiban Hydrochloride Solution concentrate for I.V. infusion equivalent to 12.5 mg tirofiban in 50 mL vial Injection 1 2 MK
Tobramycin Eye drops 3 mg per mL, 5 mL Application to the eye 1 2 AQ
Eye ointment 3 mg per g, 3.5 g Application to the eye 1 .. AQ
Tobramycin Sulfate Injection equivalent to 80 mg tobramycin in 2 mL (with preservative) Injection 10 1 MX
Injection equivalent to 80 mg tobramycin in 2 mL (without preservative) Injection 10 1 PU
Topiramate Tablet 25 mg Oral 60 5 JC
Tablet 50 mg Oral 60 5 JC
Tablet 100 mg Oral 60 5 JC
Tablet 200 mg Oral 60 5 JC
Capsule 15 mg Oral 60 5 JC
Capsule 25 mg Oral 60 5 JC
Capsule 50 mg Oral 60 5 JC
Topotecan Hydrochloride Powder for I.V. infusion equivalent to 4 mg topotecan, vial Injection 5 1 GK
Toremifene Citrate Tablet equivalent to 60 mg toremifene Oral 30 5 SH
Tramadol Hydrochloride Capsule 50 mg Oral 20 .. AF, AW, CH, CS, GX, TW
Tablet 50 mg (sustained release) Oral 20 .. CS
Tablet 100 mg (sustained release) Oral 20 .. AW, CS, HX
Tablet 150 mg (sustained release) Oral 20 .. AW, CS, HX
Tablet 200 mg (sustained release) Oral 20 .. AW, CS, HX
Oral drops 100 mg per mL, 10 mL Oral 1 .. CS
Injection 100 mg in 2 mL ampoule Injection 5 .. CS, HX
Trandolapril Capsule 500 micrograms Oral 28 5 AB, KN
Capsule 1 mg Oral 28 5 AB, KN
Capsule 2 mg Oral 28 5 AB, KN
Capsule 4 mg Oral 28 5 AB
Tranexamic Acid Tablet 500 mg Oral 100 2 PH
Tranylcypromine Sulfate Tablet equivalent to 10 mg tranylcypromine Oral 50 2 GH
Travoprost Eye drops 40 micrograms per mL, 2.5 mL Application to the eye 1 5 AQ
Travoprost with Timolol Maleate Eye drops 40 micrograms travoprost with timolol maleate equivalent to 5 mg timolol per mL, 2.5 mL Application to the eye 1 5 AQ
Triamcinolone Acetonide Injection 10 mg in 1 mL ampoule Injection 5 .. BQ
Cream 200 micrograms per g, 100 g Application 2 .. FM, SI
Ointment 200 micrograms per g, 100 g Application 2 .. FM, SI
Triamcinolone Acetonide with Neomycin Sulfate, Gramicidin and Nystatin Ear drops 1 mg-2.5 mg (neomycin)-250 micrograms-100,000 units per g, 7.5 mL Application to the ear 1 2 BC, BQ
Ear ointment 1 mg-2.5 mg (neomycin)-250 micrograms-100,000 units per g, 5 g Application to the ear 1 2 BC, BQ
Trifluoperazine Hydrochloride Tablet equivalent to 1 mg trifluoperazine Oral 100 5 GH
Tablet equivalent to 2 mg trifluoperazine Oral 100 5 GH
Tablet equivalent to 5 mg trifluoperazine Oral 100 5 GH
Triglycerides Oil - Medium Chain 500 mL Oral 2 5 SB
Trimethoprim Tablet 300 mg Oral 7 1 AF, SI
Trimethoprim with Sulfamethoxazole Tablet 80 mg-400 mg Oral 10 1 AF, SI
Tablet 160 mg-800 mg Oral 10 1 AF, CH, GX, RO, SI, TW
Paediatric oral suspension 40 mg-200 mg per 5 mL, 100 mL Oral 1 1 AF, RO, SI
Tropisetron Hydrochloride Capsule equivalent to 5 mg tropisetron Oral 2 .. NV
I.V. injection equivalent to 5 mg tropisetron in 5 mL ampoule Injection 1 .. NV
"TYR Express" Sachets containing oral powder 25 g, 30 Oral 4 5 VF
"TYR gel" Sachets containing oral powder 20 g, 30 Oral 4 5 VF
Ursodeoxycholic Acid Capsule 250 mg Oral 100 2 OA
Valaciclovir Hydrochloride Tablet equivalent to 500 mg valaciclovir Oral 20 .. GK
Vancomycin Hydrochloride Capsule equivalent to 125 mg (125,000 I.U.) vancomycin activity Oral 40 .. LY
Capsule equivalent to 250 mg (250,000 I.U.) vancomycin activity Oral 40 .. LY
Powder for injection equivalent to 500 mg (500,000 I.U.) vancomycin activity Injection 2 .. AS, MX
Venlafaxine Hydrochloride Capsule (modified release) equivalent to 37.5 mg venlafaxine Oral 28 .. WY
Capsule (modified release) equivalent to 75 mg venlafaxine Oral 28 5
Benzydamine Hydrochloride Mouth and throat rinse 22.5 mg per 15 mL, 500 mL Oral application 1 .. MM
Bisacodyl Tablet 5 mg Oral 200 .. AE, AS
Suppositories 10 mg, 10 Rectal 3 .. BY, PP
Suppositories 10 mg, 12 Rectal 3 .. FL, PP
Enemas 10 mg in 5 mL, 25 Rectal 1 .. AS
Carmellose Sodium Mouth spray 10 mg per mL, 25 mL Oral application 1 .. HA
Mouth spray 10 mg per mL, 100 mL Oral application 1 .. HA
Clonazepam Tablet 500 micrograms Oral 100 .. AF, RO
Tablet 2 mg Oral 100 .. AF, RO
Oral liquid 2.5 mg per mL, 10 mL Oral 2 .. RO
Diazepam Tablet 2 mg Oral 50 .. AF, AW, RO, SU
Tablet 5 mg Oral 50 .. AF, AW, GM, RO, SU
Diclofenac Sodium Tablet 25 mg (enteric coated) Oral 100 .. AF, AW, BG, CH, GM, GX, HX, NV, TW
Tablet 50 mg (enteric coated) Oral 50 .. AF, AW, CH, GM, GX, HX, NV, TW
Suppository 100 mg Rectal 40 .. NV
Glycerol Suppositories 700 mg, 12 Rectal 3 .. PP
Suppositories 1.4 g, 12 Rectal 3 .. PP
Suppositories 2.8 g, 12 Rectal 3 .. PP
Hyoscine Butylbromide Injection 20 mg in 1 mL ampoule Injection 5 .. BY
Ibuprofen Tablet 200 mg Oral 100 .. AF
Tablet 400 mg Oral 90 .. AB
Indomethacin Capsule 25 mg Oral 100 .. AF, MK
Suppository 100 mg Rectal 40 .. MK
Lactulose Solution BP 3.34 g per 5 mL, 500 mL Oral 1 .. AF, AW, GM, GX, HX, SM
Macrogol 3350 with Sodium Chloride, Sodium Bicarbonate and Potassium Chloride Sachets containing powder for oral solution 13.125 g-350.7 mg-178.5 mg-46.6 mg, 30 Oral 1 .. NE
Methadone Hydrochloride Oral liquid 25 mg per 5 mL, 200 mL Oral 1 .. GK
Morphine Sulfate Tablet 10 mg Oral 20 .. MF
Tablet 20 mg Oral 20 .. MF
Tablet 200 mg (controlled release) Oral 20 .. MF
Naproxen Tablet 250 mg Oral 100 .. AF, RO
Tablet 500 mg Oral 50 .. AF, RO
Tablet 750 mg (sustained release) Oral 28 .. MD, RO
Tablet 1 g (sustained release) Oral 28 .. MD, RO
Oral suspension 125 mg per 5 mL, 474 mL Oral 1 .. RO
Naproxen Sodium Tablet 550 mg Oral 50 .. MD, RO
Nitrazepam Tablet 5 mg Oral 50 .. AF, VT
Oxazepam Tablet 15 mg Oral 50 .. AF, SI
Tablet 30 mg Oral 50 .. AF, FM, SI
Paracetamol Tablet 665 mg (modified release) Oral 192 .. GC, ME
Suppositories 500 mg, 24 Rectal 1 .. GC
Promethazine Hydrochloride Tablet 10 mg Oral 50 .. AV
Tablet 25 mg Oral 50 .. AV
Oral liquid 5 mg per 5 mL, 100 mL Oral 1 .. AV
Sorbitol with Sodium Citrate and Sodium Lauryl Sulfoacetate Enemas 3.125 g-450 mg-45 mg in 5 mL, 12 Rectal 2 .. PH
Sterculia with Frangula Bark Granules 620 mg-80 mg per g, 500 g Oral 1 .. NE
Sulindac Tablet 100 mg Oral 100 .. AF
Tablet 200 mg Oral 50 .. AF
Temazepam Tablet 10 mg Oral 50 .. AF, FM, SI
Benzydamine Hydrochloride Mouth and throat rinse 22.5 mg per 15 mL, 500 mL

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where a painful mouth is a problem

Continuing supply for palliative care patients where a painful mouth is a problem, and where consultation with a palliative care specialist or service has occurred

Oral application 1 3 MM
Bisacodyl Tablet 5 mg

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where constipation is a problem

Continuing supply for palliative care patients where constipation is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 200 3 AE, AS
Suppositories 10 mg, 10

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where constipation is a problem

Continuing supply for palliative care patients where constipation is a problem, and where consultation with a palliative care specialist or service has occurred

Rectal 3 3 BY, PP
Suppositories 10 mg, 12

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where constipation is a problem

Continuing supply for palliative care patients where constipation is a problem, and where consultation with a palliative care specialist or service has occurred

Rectal 3 3 FL, PP
Enemas 10 mg in 5 mL, 25

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where constipation is a problem

Continuing supply for palliative care patients where constipation is a problem, and where consultation with a palliative care specialist or service has occurred

Rectal 1 3 AS
Carmellose Sodium Mouth spray 10 mg per mL, 25 mL

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where dry mouth is a symptom

Continuing supply for palliative care patients where dry mouth is a symptom, and where consultation with a palliative care specialist or service has occurred

Oral application 1 3 HA
Mouth spray 10 mg per mL, 100 mL

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where dry mouth is a symptom

Continuing supply for palliative care patients where dry mouth is a symptom, and where consultation with a palliative care specialist or service has occurred

Oral application 1 3 HA
Clonazepam Tablet 500 micrograms

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients for the prevention of epilepsy

Continuing supply for palliative care patients for the prevention of epilepsy, where consultation with a palliative care specialist or service has occurred

Oral 100 3 AF, RO
Tablet 2 mg

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients for the prevention of epilepsy

Continuing supply for palliative care patients for the prevention of epilepsy, where consultation with a palliative care specialist or service has occurred

Oral 100 3 AF, RO
Oral liquid 2.5 mg per mL, 10 mL

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients for the prevention of epilepsy

Continuing supply for palliative care patients for the prevention of epilepsy, where consultation with a palliative care specialist or service has occurred

Oral 2 3 RO
Diazepam Tablet 2 mg

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where anxiety is a problem

Continuing supply for palliative care patients where anxiety is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 50 3 AF, AW, RO, SU
Tablet 5 mg

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where anxiety is a problem

Continuing supply for palliative care patients where anxiety is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 50 3 AF, AW, GM, RO, SU
Diclofenac Sodium Tablet 25 mg (enteric coated)

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem

Continuing supply for palliative care patients where severe pain is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 100 3 AF, AW, BG, CH, GM, GX, HX, NV, TW
Tablet 50 mg (enteric coated)

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem

Continuing supply for palliative care patients where severe pain is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 50 3 AF, AW, CH, GM, GX, HX, NV, TW
Suppository 100 mg

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem

Continuing supply for palliative care patients where severe pain is a problem, and where consultation with a palliative care specialist or service has occurred

Rectal 40 3 NV
Glycerol Suppositories 700 mg, 12

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where constipation is a problem

Continuing supply for palliative care patients where constipation is a problem, and where consultation with a palliative care specialist or service has occurred

Rectal 3 3 PP
Suppositories 1.4 g, 12

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where constipation is a problem

Continuing supply for palliative care patients where constipation is a problem, and where consultation with a palliative care specialist or service has occurred

Rectal 3 3 PP
Suppositories 2.8 g, 12

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where constipation is a problem

Continuing supply for palliative care patients where constipation is a problem, and where consultation with a palliative care specialist or service has occurred

Rectal 3 3 PP
Hyoscine Butylbromide Injection 20 mg in 1 mL ampoule

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where colicky pain is a symptom

Continuing supply for palliative care patients where colicky pain is a symptom, and where consultation with a palliative care specialist or service has occurred

Injection 5 3 BY
Ibuprofen Tablet 200 mg

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem

Continuing supply for palliative care patients where severe pain is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 100 3 AF
Tablet 400 mg

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem

Continuing supply for palliative care patients where severe pain is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 90 3 AB
Indomethacin Capsule 25 mg

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem

Continuing supply for palliative care patients where severe pain is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 100 3 AF, MK
Suppository 100 mg

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem

Continuing supply for palliative care patients where severe pain is a problem, and where consultation with a palliative care specialist or service has occurred

Rectal 40 3 MK
Lactulose Solution BP 3.34 g per 5 mL, 500 mL

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where constipation is a problem

Continuing supply for palliative care patients where constipation is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 1 3 AF, AW, GM, GX, HX, SM
Macrogol 3350 with Sodium Chloride, Sodium Bicarbonate and Potassium Chloride Sachets containing powder for oral solution 13.125 g-350.7 mg-178.5 mg-46.6 mg, 30

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where constipation is a problem

Continuing supply for palliative care patients where constipation is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 1 3 NE
Methadone Hydrochloride Oral liquid 25 mg per 5 mL, 200 mL

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 3 months, for palliative care patients with chronic severe disabling pain not responding to non-narcotic analgesics

Continuing supply, for up to 3 months, for palliative care patients with chronic severe disabling pain not responding to non-narcotic analgesics, and where consultation with a palliative care specialist or service has occurred

Oral 1 2 GK
Morphine Sulfate Tablet 10 mg

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 3 months, for palliative care patients with severe disabling pain not responding to non-narcotic analgesics

Continuing supply, for up to 3 months, for palliative care patients with severe disabling pain not responding to non-narcotic analgesics, and where consultation with a palliative care specialist or service has occurred

Oral 20 2 MF
Tablet 20 mg

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 3 months, for palliative care patients with severe disabling pain not responding to non-narcotic analgesics

Continuing supply, for up to 3 months, for palliative care patients with severe disabling pain not responding to non-narcotic analgesics, and where consultation with a palliative care specialist or service has occurred

Oral 20 2 MF
Tablet 200 mg (controlled release)

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 3 months, for palliative care patients with chronic severe disabling pain not responding to non-narcotic analgesics

Continuing supply, for up to 3 months, for palliative care patients with chronic severe disabling pain not responding to non-narcotic analgesics, and where consultation with a palliative care specialist or service has occurred

Oral 20 2 MF
Naproxen Tablet 250 mg

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem

Continuing supply for palliative care patients where severe pain is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 100 3 AF, RO
Tablet 500 mg

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem

Continuing supply for palliative care patients where severe pain is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 50 3 AF, RO
Tablet 750 mg (sustained release)

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem

Continuing supply for palliative care patients where severe pain is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 28 3 MD, RO
Tablet 1 g (sustained release)

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem

Continuing supply for palliative care patients where severe pain is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 28 3 MD, RO
Oral suspension 125 mg per 5 mL, 474 mL

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem in patients unable to take a solid dose form of a non-steroidal anti-inflammatory agent

Continuing supply for palliative care patients where severe pain is a problem in patients unable to take a solid dose form of a non-steroidal anti-inflammatory agent, and where consultation with a palliative care specialist or service has occurred

Oral 1 3 RO
Naproxen Sodium Tablet 550 mg

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem

Continuing supply for palliative care patients where severe pain is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 50 3 MD, RO
Nitrazepam Tablet 5 mg

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where insomnia is a problem

Continuing supply for palliative care patients where insomnia is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 50 3 AF, VT
Oxazepam Tablet 15 mg

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where anxiety is a problem

Continuing supply for palliative care patients where anxiety is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 50 3 AF, SI
Tablet 30 mg

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where anxiety is a problem

Continuing supply for palliative care patients where anxiety is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 50 3 AF, FM, SI
Paracetamol Tablet 665 mg (modified release)

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients for analgesia or fever where alternative therapy cannot be tolerated

Continuing supply for palliative care patients for analgesia or fever where alternative therapy cannot be tolerated, and where consultation with a palliative care specialist or service has occurred

Oral 192 3 GC, ME
Suppositories 500 mg, 24

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients for analgesia or fever where alternative therapy cannot be tolerated

Continuing supply for palliative care patients for analgesia or fever where alternative therapy cannot be tolerated, and where consultation with a palliative care specialist or service has occurred

Rectal 1 3 GC
Promethazine Hydrochloride Tablet 10 mg

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where nausea and/or vomiting is a problem

Continuing supply for palliative care patients where nausea and/or vomiting is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 50 3 AV
Tablet 25 mg

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where nausea and/or vomiting is a problem

Continuing supply for palliative care patients where nausea and/or vomiting is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 50 3 AV
Oral liquid 5 mg per 5 mL, 100 mL

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where nausea and/or vomiting is a problem

Continuing supply for palliative care patients where nausea and/or vomiting is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 1 3 AV
Sorbitol with Sodium Citrate and Sodium Lauryl Sulfoacetate Enemas 3.125 g-450 mg-45 mg in 5 mL, 12

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where constipation is a problem

Continuing supply for palliative care patients where constipation is a problem, and where consultation with a palliative care specialist or service has occurred

Rectal 2 3 PH
Sterculia with Frangula Bark Granules 620 mg-80 mg per g, 500 g

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where constipation is a problem

Continuing supply for palliative care patients where constipation is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 1 3 NE
Sulindac Tablet 100 mg

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem

Continuing supply for palliative care patients where severe pain is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 100 3 AF
Tablet 200 mg

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem

Continuing supply for palliative care patients where severe pain is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 50 3 AF
Temazepam Tablet 10 mg

In compliance with authority procedures set out in subparagraph 11 (d):

Initial supply, for up to 4 months, for palliative care patients where insomnia is a problem

Continuing supply for palliative care patients where insomnia is a problem, and where consultation with a palliative care specialist or service has occurred

Oral 50 3 AF, FM, SI
Adrenaline Acid Tartrate Injection equivalent to adrenaline 1 in 1,000, 1 mL Injection 5 .. AP
Amoxycillin Trihydrate Tablet, chewable, equivalent to 250 mg amoxycillin Oral 20 .. GK
Capsule equivalent to 250 mg amoxycillin Oral 20 .. AF, CH, GK, GM, GX, HX, SI, TW
Capsule equivalent to 500 mg amoxycillin Oral 20 .. AF, CH, CS, GK, GM, GX, HX, SI, TW
Sachet containing oral powder equivalent to 3 g amoxycillin Oral 1 .. GK
Amoxycillin Trihydrate with Potassium Clavulanate Tablet equivalent to 500 mg amoxycillin-125 mg clavulanic acid Oral 10 .. AL, AW, GK, HX, ME, SL, SZ
Tablet equivalent to 875 mg amoxycillin-125 mg clavulanic acid Oral 10 .. AL, AW, CH, GK, GX, HX, ME, SL, SZ, TW
Amoxycillin Trihydrate with Potassium Clavulanate and Water - Purified BP Powder for oral suspension equivalent to 125 mg amoxycillin-31.25 mg clavulanic acid per 5 mL, 75 mL Oral 1 .. AL, GK, HX, ME
Powder for oral suspension equivalent to 400 mg amoxycillin-57 mg clavulanic acid per 5 mL, 60 mL Oral 1 .. AL, GK, HX, ME
Amoxycillin Trihydrate with Water - Purified BP Powder for paediatric oral drops equivalent to 100 mg amoxycillin per mL, 20 mL Oral 1 .. GK
Powder for oral suspension equivalent to 125 mg amoxycillin per 5 mL, 100 mL Oral 1 .. AF, CH, GK, GM, GX, HX, TW
Powder for oral suspension equivalent to 250 mg amoxycillin per 5 mL, 100 mL Oral 1 .. AF, CH, GK, GM, GX, HX, SI, TW
Powder for oral suspension equivalent to 500 mg amoxycillin per 5 mL, 100 mL Oral 1 .. SZ
Amphotericin Lozenge 10 mg Oral 20 .. BQ
Ampicillin Sodium Powder for injection equivalent to 500 mg ampicillin Injection 5 .. GM, LN
Powder for injection equivalent to 1 g ampicillin Injection 5 .. AS, GM, LN
Ampicillin Trihydrate Capsule equivalent to 250 mg ampicillin Oral 24 .. AF
Capsule equivalent to 500 mg ampicillin Oral 24 .. AF
Aspirin Tablet, dispersible, 300 mg Oral 96 .. RC
Atropine Sulfate Injection 600 micrograms in 1 mL ampoule Injection 10 .. AP
Benzathine Penicillin Injection 900 mg in 2 mL cartridge-needle unit (for use with Tubex Injector) Injection 1 .. AS
Powder for injection 900 mg Injection 1 .. AS
Benztropine Mesylate Injection 2 mg in 2 mL ampoule Injection 5 .. MK
Benzydamine Hydrochloride Mouth and throat rinse 22.5 mg per 15 mL, 500 mL Oral application 1 .. MM
Benzylpenicillin Sodium Powder for injection equivalent to 600 mg benzylpenicillin Injection 10 .. CS
Powder for injection equivalent to 3 g benzylpenicillin Injection 10 .. CS
Betamethasone Acetate with Betamethasone Sodium Phosphate Injection 3 mg-3.9 mg in 1 mL ampoule Injection 5 .. SH
Carbamazepine Tablet 100 mg Oral 200 .. BG, NV, SZ
Tablet 200 mg Oral 200 .. AF, BG, NV, SZ
Tablet 200 mg (controlled release) Oral 200 .. NV
Tablet 400 mg (controlled release) Oral 200 .. NV
Oral suspension 100 mg per 5 mL, 300 mL Oral 1 .. NV
Cefaclor Monohydrate Tablet (sustained release) equivalent to 375 mg cefaclor Oral 10 .. AF, AS, CH, GM, GX, LN, RA, TW
Cefaclor Monohydrate with Water - Purified BP Powder for oral suspension equivalent to 125 mg cefaclor per 5 mL, 100 mL Oral 1 .. AF, AS, AW, CH, GX, TW
Powder for oral suspension equivalent to 250 mg cefaclor per 5 mL, 75 mL Oral 1 .. AF, AS, AW, CH, GX, TW
Cefotaxime Sodium Powder for injection equivalent to 1 g cefotaxime Injection 10 .. MX, SZ
Powder for injection equivalent to 2 g cefotaxime Injection 10 .. MX, SZ
Cefuroxime Axetil Tablet equivalent to 250 mg cefuroxime Oral 14 .. GK
Cephalexin Capsule 250 mg (anhydrous) Oral 20 .. AF, AS, CH, GM, GX, HX, LN, RA, TW
Capsule 500 mg (anhydrous) Oral 20 .. AF, AS, CH, GM, GX, HX, LN, RA, TW
Cephalexin with Water - Purified BP Granules for oral suspension 125 mg per 5 mL, 100 mL Oral 1 .. AF, AS, CH, GM, GX, LN, TW
Granules for oral suspension 250 mg per 5 mL, 100 mL Oral 1 .. AF, AS, CH, GM, GX, LN, TW
Cephalothin Sodium Powder for injection equivalent to 1 g cephalothin Injection 10 .. AS, MX
Chloramphenicol Eye drops 5 mg per mL, 10 mL Application to the eye 1 .. PF, SI
Clindamycin Hydrochloride Capsule equivalent to 150 mg clindamycin Oral 25 .. KR, PH
Codeine Phosphate Tablet 30 mg Oral 20 .. FM
Codeine Phosphate with Paracetamol Tablet 30 mg-500 mg Oral 20 .. AL, CO, DK, FM, GK, SW
Diazepam Tablet 2 mg Oral 50 .. AF, AW, RO, SU
Tablet 5 mg Oral 50 .. AF, AW, GM, RO, SU
Injection 10 mg in 2 mL ampoule Injection 5 .. MX
Diclofenac Sodium Tablet 25 mg (enteric coated) Oral 100 .. AF, AW, BG, CH, GM, GX, HX, NV, TW
Tablet 50 mg (enteric coated) Oral 50 .. AF, AW, CH, GM, GX, HX, NV, TW
Suppository 100 mg Rectal 40 .. NV
Dicloxacillin Sodium Capsule equivalent to 250 mg dicloxacillin Oral 24 .. AF, BQ, SI
Capsule equivalent to 500 mg dicloxacillin Oral 24 .. AF, BQ, SI
Powder for injection equivalent to 500 mg dicloxacillin Injection 5 .. BQ
Powder for injection equivalent to 1 g dicloxacillin Injection 5 .. BQ
Doxycycline Hydrochloride Tablet equivalent to 100 mg doxycycline Oral 7 .. AF, GM, PF, SI
Capsule equivalent to 100 mg doxycycline (containing enteric coated pellets) Oral 7 .. FA, MX
Doxycycline Monohydrate Tablet equivalent to 100 mg doxycycline Oral 7 .. CH, GX, SZ, TW
Erythromycin Capsule 250 mg (containing enteric coated pellets) Oral 25 .. FA, MX
Erythromycin Ethyl Succinate Tablet equivalent to 400 mg erythromycin Oral 25 .. AB, AF
Erythromycin Ethyl Succinate with Water - Purified BP Powder for oral liquid equivalent to 200 mg erythromycin per 5 mL, 100 mL Oral 1 .. AB, AF
Powder for oral liquid equivalent to 400 mg erythromycin per 5 mL, 100 mL Oral 1 .. AB, AF
Erythromycin Lactobionate Powder for I.V. infusion equivalent to 1 g erythromycin, vial Injection 5 .. AB
Flucloxacillin Magnesium with Water - Purified BP Powder for oral suspension equivalent to 125 mg flucloxacillin per 5 mL, 100 mL Oral 1 .. GK
Powder for oral suspension equivalent to 250 mg flucloxacillin per 5 mL, 100 mL Oral 1 .. CS, GK
Flucloxacillin Sodium Capsule equivalent to 250 mg flucloxacillin Oral 24 .. AF, CS, GK, SI
Capsule equivalent to 500 mg flucloxacillin Oral 24 .. AF, CS, GK, SI
Powder for injection equivalent to 500 mg flucloxacillin Injection 5 .. CS, GM
Powder for injection equivalent to 1 g flucloxacillin Injection 5 .. AS, CS, GM, MX
Glucagon Hydrochloride Injection set containing 1 mg (1 I.U.) and 1 mL solvent in disposable syringe Injection 1 .. NO
Glucose I.V. infusion 278 mmol (anhydrous) per L, 1 L Injection 5 .. BX
Glyceryl Trinitrate Tablets 600 micrograms, 100 Oral 1 .. FM, SI
Hydrocortisone Acetate Cream 10 mg per g, 30 g Application 1 .. FM, SI
Cream 10 mg per g, 50 g Application 1 .. DT, FM, SI
Ointment 10 mg per g, 30 g Application 1 .. FM, SI
Ointment 10 mg per g, 50 g Application 1 .. FM, SI
Hydrocortisone Sodium Succinate Injection equivalent to 100 mg hydrocortisone with 2 mL solvent Injection 6 .. PH
Injection equivalent to 250 mg hydrocortisone with 2 mL solvent Injection 6 .. PH
Hydromorphone Hydrochloride Tablet 2 mg Oral 20 .. AB
Tablet 4 mg Oral 20 .. AB
Tablet 8 mg Oral 20 .. AB
Oral liquid 1 mg per mL, 473 mL Oral 1 .. AB
Injection 2 mg in 1 mL ampoule Injection 5 .. AB
Injection 10 mg in 1 mL ampoule Injection 5 .. AB
Injection 50 mg in 5 mL ampoule Injection 5 .. AB
Ibuprofen Tablet 200 mg Oral 100 .. AF
Tablet 400 mg Oral 30 .. AB
Indomethacin Capsule 25 mg Oral 100 .. AF, MK
Suppository 100 mg Rectal 40 .. MK
Ketoprofen Capsule 200 mg (sustained release) Oral 28 .. AV, HP
Suppository 100 mg Rectal 40 .. AV
Lignocaine Hydrochloride Injection 100 mg in 5 mL Injection 5 .. PF
Lincomycin Hydrochloride Injection equivalent to 600 mg lincomycin in 2 mL vial Injection 5 .. PH
Methylprednisolone Acetate Injection 40 mg in 1 mL vial Injection 5 .. KR, PH
Metoclopramide Hydrochloride Tablet 10 mg Oral 25 .. AF, VT
Oral solution 5 mg per 5 mL, 100 mL Oral 1 .. VT
Injection 10 mg in 2 mL ampoule Injection 10 .. VT
Metronidazole Tablet 200 mg Oral 21 .. AF, AV, HP
Tablet 400 mg Oral 5 .. AF
I.V. infusion 500 mg in 100 mL Injection 5 .. BX
Suppositories 500 mg, 10 Rectal 1 .. AV
Metronidazole Benzoate Oral suspension 320 mg per 5 mL, 100 mL Oral 1 .. AV
Morphine Hydrochloride Oral solution 2 mg per mL, 200 mL Oral 1 .. MF
Oral solution 5 mg per mL, 200 mL Oral 1 .. MF
Oral solution 10 mg per mL, 200 mL Oral 1 .. MF
Morphine Sulfate Tablet 30 mg Oral 20 .. FM
Tablet 5 mg (controlled release) Oral 20 .. MF
Tablet 10 mg (controlled release) Oral 20 .. MF
Tablet 15 mg (controlled release) Oral 20 .. MF
Tablet 30 mg (controlled release) Oral 20 .. MF
Tablet 60 mg (controlled release) Oral 20 .. MF
Tablet 100 mg (controlled release) Oral 20 .. MF
Capsule 10 mg (containing sustained release pellets) Oral 20 .. GK
Capsule 20 mg (containing sustained release pellets) Oral 20 .. GK
Capsule 30 mg (controlled release) Oral 10 .. MF
Capsule 50 mg (containing sustained release pellets) Oral 20 .. GK
Capsule 60 mg (controlled release) Oral 10 .. MF
Capsule 90 mg (controlled release) Oral 10 .. MF
Capsule 100 mg (containing sustained release pellets) Oral 20 .. GK
Capsule 120 mg (controlled release) Oral 10 .. MF
Sachet containing controlled release granules for oral suspension, 20 mg per sachet Oral 20 .. MF
Sachet containing controlled release granules for oral suspension, 30 mg per sachet Oral 20 .. MF
Sachet containing controlled release granules for oral suspension, 60 mg per sachet Oral 20 .. MF
Sachet containing controlled release granules for oral suspension, 100 mg per sachet Oral 20 .. MF
Injection 10 mg in 1 mL ampoule Injection 5 .. MX
Injection 15 mg in 1 mL ampoule Injection 5 .. MX
Injection 30 mg in 1 mL ampoule Injection 5 .. MX
Naloxone Hydrochloride Injection 800 micrograms in 2 mL disposable injection set Injection 1 .. CS
Injection 2 mg in 5 mL disposable injection set Injection 1 .. CS
Naproxen Tablet 250 mg Oral 100 .. AF, RO
Tablet 500 mg Oral 50 .. AF, RO
Tablet 750 mg (sustained release) Oral 28 .. MD, RO
Tablet 1 g (sustained release) Oral 28 .. MD, RO
Naproxen Sodium Tablet 550 mg Oral 50 .. MD, RO
Nitrazepam Tablet 5 mg Oral 25 .. AF, VT
Nystatin Tablet 500,000 units Oral 50 .. SI
Capsule 500,000 units Oral 50 .. SI
Oral suspension 100,000 units per mL, 24 mL Oral 1 .. BQ, SI
Oxazepam Tablet 15 mg Oral 25 .. AF, SI
Tablet 30 mg Oral 25 .. AF, FM, SI
Oxycodone Hydrochloride Tablet 5 mg Oral 20 .. SI
Capsule 5 mg Oral 20 .. MF
Capsule 10 mg Oral 20 .. MF
Capsule 20 mg Oral 20 .. MF
Oral solution 5 mg per 5 mL, 250 mL Oral 1 .. MF
Tablet 5 mg (controlled release) Oral 20 .. MF
Tablet 10 mg (controlled release) Oral 20 .. MF
Tablet 20 mg (controlled release) Oral 20 .. MF
Tablet 40 mg (controlled release) Oral 20 .. MF
Tablet 80 mg (controlled release) Oral 20 .. MF
Oxycodone Pectinate Suppository equivalent to 30 mg oxycodone Rectal 12 .. PL
Paracetamol Tablet 500 mg Oral 100 .. AW, CH, FM, GM, HX, JT, PC, SW, TW
Oral liquid 120 mg per 5 mL, 100 mL Oral 1 .. SW
Oral liquid 240 mg per 5 mL, 200 mL Oral 1 .. SW
Phenoxymethylpenicillin Benzathine Oral suspension equivalent to 125 mg phenoxymethylpenicillin per 5 mL, 100 mL Oral 2 .. FM, SI
Oral suspension equivalent to 250 mg phenoxymethylpenicillin per 5 mL, 100 mL Oral 2 .. FM, SI
Phenoxymethylpenicillin Potassium Tablet equivalent to 250 mg phenoxymethylpenicillin Oral 50 .. SI
Tablet equivalent to 500 mg phenoxymethylpenicillin Oral 50 .. SI
Capsule equivalent to 250 mg phenoxymethylpenicillin Oral 50 .. CS, FM, GM, HX
Capsule equivalent to 500 mg phenoxymethylpenicillin Oral 50 .. CS, FM, GM, HX
Piroxicam Dispersible tablet 10 mg Oral 50 .. AF, GX, HX, PF
Dispersible tablet 20 mg Oral 25 .. AF, CH, GX, HX, PF, TW
Capsule 10 mg Oral 50 .. AF, CH, GX, PF, TW
Capsule 20 mg Oral 25 .. AF, CH, GX, PF, TW
Procaine Penicillin Injection 1.5 g in disposable syringe Injection 5 .. SI
Prochlorperazine Suppositories 3 mg, equivalent to 5 mg prochlorperazine maleate, 5 Rectal 1 .. AV
Suppositories 15 mg, equivalent to 25 mg prochlorperazine maleate, 5 Rectal 1 .. AV
Prochlorperazine Maleate Tablet 5 mg Oral 25 .. AV, HP
Prochlorperazine Mesylate Injection 12.5 mg in 1 mL ampoule Injection 10 .. AV
Promethazine Hydrochloride Injection 50 mg in 2 mL ampoule Injection 10 .. MX
Sodium Chloride Injection 9 mg per mL, 10 mL Injection 5 .. PF
I.V. infusion 154 mmol per L, 1 L Injection 5 .. BX
I.V. infusion 513 mmol per L, 1 L Injection 2 .. BX
Sodium Chloride with Glucose I.V. infusion 31 mmol-222 mmol (anhydrous) per L, 1 L Injection 5 .. BX
I.V. infusion 19 mmol-104 mmol (anhydrous) per 500 mL, 500 mL Injection 5 .. BX
I.V. infusion 39 mmol-69 mmol (anhydrous) per 500 mL, 500 mL Injection 5 .. BX
Sulindac Tablet 100 mg Oral 100 .. AF
Tablet 200 mg Oral 50 .. AF
Temazepam Tablet 10 mg Oral 25 .. AF, FM, SI
Ticarcillin Sodium with Potassium Clavulanate with any determined brand of Sodium Chloride Injection Powder for injection equivalent to 3 g ticarcillin-100 mg clavulanic acid (with required solvent) Injection 10 .. GK
Tramadol Hydrochloride Capsule 50 mg Oral 20 .. AF, AW, CH, CS, GX, TW
Tablet 50 mg (sustained release) Oral 20 .. CS
Tablet 100 mg (sustained release) Oral 20 .. AW, CS, HX
Tablet 150 mg (sustained release) Oral 20 .. AW, CS, HX
Tablet 200 mg (sustained release) Oral 20 .. AW, CS, HX
Oral drops 100 mg per mL, 10 mL Oral 1 .. CS
Injection 100 mg in 2 mL ampoule Injection 5 .. CS, HX
Triamcinolone Acetonide Injection 10 mg in 1 mL ampoule Injection 5 .. BQ
Trimethoprim with Sulfamethoxazole Tablet 80 mg-400 mg Oral 10 .. AF, SI
Tablet 160 mg-800 mg Oral 10 .. AF, CH, GX, RO, SI, TW
Paediatric oral suspension 40 mg-200 mg per 5 mL, 100 mL Oral 1 .. AF, RO, SI
Vancomycin Hydrochloride Powder for injection equivalent to 500 mg (500,000 I.U.) vancomycin activity Injection 2 .. AS, MX
Ibuprofen Tablet 400 mg

Chronic arthropathies (including osteoarthritis) with an inflammatory component

Bone pain due to malignant disease

Oral 90 .. AB
Metronidazole Tablet 400 mg Treatment of anaerobic infections Oral 21 .. AF, AV, HP
Paracetamol Tablet 500 mg Chronic arthropathies Oral 300 .. AW, CH, FM, GM, HX, JT, PC, SW, TW
Creams 100 g 1
Dusting Powders 100 g 1
Ear Drops 15 mL 2
Eye Drops containing Cocaine Hydrochloride BP 15 mL ..
Eye Drops, Other 15 mL 5
Eye Lotions 200 mL 2
Inhalations 50 mL 1
Linctuses containing Codeine Phosphate BP 100 mL ..
Linctuses, Other 100 mL 2
Lotions 200 mL 2
Mixtures containing Codeine Phosphate BP 200 mL ..
Mixtures, Other 200 mL 4
Mixtures for Children containing Codeine Phosphate BP 100 mL ..
Mixtures for Children, Other 100 mL 4
Mouth Washes 200 mL 1
Nasal Instillations 15 mL 2
Ointments, Waxes 100 g 1
Paints 25 mL 1
Pastes containing Cocaine Hydrochloride BP 25 g ..
Pastes, Other 100 g 1
Powders for Internal Use 100 g 2
Solutions 200 mL 2

Dated this 12 day of  March 2007.

STEPHEN DELLAR

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Delegate of the Minister for Health and Ageing

Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0